heiBIB: Marmé, Frederik

Marmé, Frederik Prof. Dr.Universität HeidelbergHeidelberg

Publikationsliste einschränken

Publikationsjahre

Publikationstypen

Liste

Sprache

englisch (251)
deutsch (11)

Co-Autoren (Uni Heidelberg)

mehr ...

Co-Autoren (extern)

mehr ...

Publikationen in heiBIB

Marmé, Frederik: PRIMA : captivated by the wizard of OS? / Frederik Marmé, Jan 15, 2025. - 6 S.
In: Journal of gynecologic oncology, ISSN 2005-0399. 36(2024), 1, Seite 1-6
DOI: 10.3802/jgo.2025.36.e55
Marmé, Frederik: Antikörper-Wirkstoff-Konjugate in der gynäkologischen Onkologie / Frederik Marmé ; unter Mitarbeit von Florian Heitz, Sabine Heublein, Aurelia Noske, Marcus Schmidt, … . - 1. Auflage. -
Bremen ; London ; Boston: UNI-MED Verlag AG, 2025. - 95 Seiten : Diagramme, ISBN 978-3-8374-1656-5
(UNI-MED Science)
Rugo, Hope S.: Q-TWiST analysis of sacituzumab govitecan vs. chemotherapy in previously treated patients with HR+/HER2− metastatic breast cancer / Hope S. Rugo, Aditya Bardia, Peter Schmid, Sara M. Tolaney, Anandaroop Dasgupta, Ankita Kaushik, Wen… , 15 March 2025. - 10 S. : Illustrationen
In: Current oncology, ISSN 1718-7729. 32(2025), 3, Artikel-ID 169, Seite 1-10
DOI: 10.3390/curroncol32030169
Tauber, Nikolas: Therapy of early breast cancer : current status and perspectives : review / Nikolas Tauber, Niklas Amann, Dominik Dannehl, Thomas M. Deutsch, Moritz Dimpfl, Peter Fasching, And… , 22 April 2025. - 18 S. : Diagramme
In: Archives of gynecology and obstetrics, ISSN 1432-0711. (2025), Seite 1-18
DOI: 10.1007/s00404-025-08028-0
Michel, Laura L.: Efficacy of hand cooling and compression in preventing taxane-induced neuropathy : the POLAR randomized clinical trial / Laura L. Michel, MD, Daniel Schwarz, MD, Philipp Romar, MD, Manuel Feisst, PhD, Daniel Hamberger, MD… , March 6, 2025. - 8 S.
In: JAMA oncology, ISSN 2374-2445. 11(2025), 4, Seite 408-415
DOI: 10.1001/jamaoncol.2025.0001
Matulonis, Ursula A.: ENGOT-OV16/NOVA trial of niraparib in recurrent ovarian cancer : survival and long-term safety / Ursula A. Matulonis, Jørn Herrstedt, Amit Oza, Sven Mahner, Andrés Redondo, Dominique Berton, Jonath… , April 2025. - 8 S. : Diagramme
In: Gynecologic oncology, ISSN 1095-6859. 195(2025) vom: Apr., Seite 192-199
DOI: 10.1016/j.ygyno.2025.03.018
Villacampa, Guillermo: RAD51 testing in patients with early HER2-negative breast cancer and homologous recombination deficiency : a post hoc analysis of the GeparOLA trial / Guillermo Villacampa, Alba Llop-Guevara, Natalie Filmann, Andrea Herencia-Ropero, Peter A. Fasching,… , 1 March 2025. - 7 S. : Illustrationen
In: Clinical cancer research, ISSN 1557-3265. 31(2025), 5, Seite 808-814
DOI: 10.1158/1078-0432.CCR-24-3148
Hahnen, Eric Thomas: BRCA1/2 and other predisposition genes in high-risk hormone receptor+/human epidermal growth factor receptor 2- breast cancer treated with endocrine therapy with or without palbociclib : a secondary PENELOPE-B study analysis : original reports : biomarkers / Eric Hahnen, PhD1, Jan Hauke, PhD, Karen Gelmon, MD, Frederik Marmé, MD, Corinna Ernst, PhD, Miguel… , April 10, 2025. - 9 S. : Diagramme
In: JCO precision oncology, ISSN 2473-4284. (2025), 9, Artikel-ID e2400742, Seite 1-9
DOI: 10.1200/PO-24-00742
Conforti, Fabio: Surrogate end points for overall survival in neoadjuvant randomized clinical trials for early breast cancer : original reports : breast cancer / Fabio Conforti, MD, Valentina Nekljudova, PhD, Isabella Sala, MSc, Roberto Ascari, PhD, Christine So… , January 30, 2025. - 14 S. : Diagramme
In: Journal of clinical oncology, ISSN 1527-7755. 43(2025), 12, Seite 1441-1452
DOI: 10.1200/JCO-24-01360
Mirza, Mansoor R.: Palbociclib plus letrozole in estrogen receptor-positive advanced/recurrent endometrial cancer : double-blind placebo-controlled randomized phase II ENGOT-EN3/PALEO trial / Mansoor R. Mirza, Line Bjørge, Frederik Marmé, René DePont Christensen, Marta Gil-Martin, Annika Aur… , January 2025. - 9 S. : Diagramme
In: Gynecologic oncology, ISSN 1095-6859. 192(2025) vom: Jan., Seite 128-136
DOI: 10.1016/j.ygyno.2024.12.003
Montégut, Coline: Safety and quality of life with maintenance olaparib plus bevacizumab in older patients with ovarian cancer : subgroup analysis of PAOLA‑1/ENGOT-ov25 / Coline Montégut, Claire Falandry, Saverio Cinieri, Claire Cropet, Laure Montane, Frédérique Rousseau… , 2024. - 12 S. : Illustrationen
In: The oncologist, ISSN 1549-490X. (2024), Artikel-ID oyae322, Seite 1-12
DOI: 10.1093/oncolo/oyae322
Denkert, Carsten: Molecular adaptation to neoadjuvant immunotherapy in triple-negative breast cancer / Carsten Denkert, Andreas Schneeweiss, Julia Rey, Thomas Karn, Akira Hattesohl, Karsten E. Weber, Siv… , 19 November 2024. - 12 S.
In: Cell reports, ISSN 2666-3791. 5(2024), 11, Artikel-ID 101825, Seite 1-12
DOI: 10.1016/j.xcrm.2024.101825
Harbeck, Nadia: Publisher correction: Trastuzumab deruxtecan in HER2-positive advanced breast cancer with or without brain metastases: a phase 3b/4 trial / Nadia Harbeck, Eva Ciruelos, Guy Jerusalem, Volkmar Müller, Naoki Niikura, Giuseppe Viale, Rupert Ba… , December 2024. - 1 S.
In: Nature medicine, ISSN 1546-170X. 30(2024), 12 vom: Dez., Seite 3780-3780
DOI: 10.1038/s41591-024-03349-0
Harbeck, Nadia: Trastuzumab deruxtecan in HER2-positive advanced breast cancer with or without brain metastases : a phase 3b/4 trial / Nadia Harbeck, Eva Ciruelos, Guy Jerusalem, Volkmar Müller, Naoki Niikura, Giuseppe Viale, Rupert Ba… , December 2024. - 11 S.
In: Nature medicine, ISSN 1546-170X. 30(2024), 12 vom: Dez., Seite 3717-3727
DOI: 10.1038/s41591-024-03261-7
Hack, Carolin Christine: Long-term follow-up and safety of patients after an upfront therapy with Letrozole for early breast cancer in routine clinical care : the PreFace study : GebFra Science / authors: Carolin C. Hack, Nicolai Maass, Bahriye Aktas, Sherko Kümmel, Christoph Thomssen, Christoph… , 08. Februar 2024. - 11 S. : Diagramme
In: Geburtshilfe und Frauenheilkunde, ISSN 1438-8804. 84(2024), 2, Seite 185-195
DOI: 10.1055/a-2238-3153
Reinisch, Mattea: ASCO 2024: personal Insights and a look into the future from an international expert group : expert discussion / Mattea Reinisch, Paolo Tarantino, Nina Ditsch, Angelika Wolfrum, Frederik Marmé, August 2024. - 6 S.
In: Breast care, ISSN 1661-3805. 19(2024), 4 vom: Aug., Seite 223-228
DOI: 10.1159/000539869
Gebhart, Geraldine: Optimal (18F)FDG PET/CT cutoff for pathologic complete response in HER2-positive early breast cancer patients treated with neoadjuvant trastuzumab and pertuzumab in the PHERgain trial / Geraldine Gebhart, Marleen Keyaerts, Thomas Guiot, Patrick Flamen, Manuel Ruiz-Borrego, Agostina Str… , May 1, 2024. - 6 S. : Illustrationen
In: Journal of nuclear medicine, ISSN 2159-662X. 65(2024), 5, Seite 708-713
DOI: 10.2967/jnumed.123.266384
Di Cosimo, Serena: Impact of coadministration of proton-pump inhibitors and palbociclib in hormone receptor-positive/HER2-negative advanced breast cancer / Serena Di Cosimo, José Manuel Pérez-García, Meritxell Bellet, Florence Dalenc, Miguel J. Gil Gil, Ma… , August 2024. - 10 S.
In: The breast, ISSN 1532-3080. 76(2024) vom: Aug., Artikel-ID 103761, Seite 1-10
DOI: 10.1016/j.breast.2024.103761
Möbus, Volker: GAIN2 trial overall survival with intense versus tailored dose dense chemotherapy in early breast cancer / Volker Möbus, Hans-Joachim Lück, Ekkehart Ladda, Peter Klare, Knut Engels, Marcus Schmidt, Andreas S… , 30 July 2024. - 10 S. : Illustrationen
In: npj Breast cancer, ISSN 2374-4677. 10(2024), 1, Seite 1-10
DOI: 10.1038/s41523-024-00675-x
Perez-Garcia, Jose Manuel: 3-year invasive disease-free survival with chemotherapy de-escalation using an 18F-FDG-PET-based, pathological complete response-adapted strategy in HER2-positive early breast cancer (PHERGain) : a randomised, open-label, phase 2 trial / José Manuel Pérez-García, Javier Cortés, Manuel Ruiz-Borrego, Marco Colleoni, Agostina Stradella, Be… , 27 April-3 May 2024. - 11 S.
In: The lancet, ISSN 1474-547X. 403(2024), 10437 vom: Apr./Mai, Seite 1649-1659
DOI: 10.1016/S0140-6736(24)00054-0
Marmé, Frederik: Palbociclib combined with endocrine treatment in hormone receptor-positive, HER2-negative breast cancer patients with high relapse risk after neoadjuvant chemotherapy : subgroup analyses of premenopausal patients in PENELOPE-B / F. Marmé, M. Martin, M. Untch, C. Thode, H. Bonnefoi, S.-B. Kim, H. Bear, N. Mc Carthy, K. Gelmon, J… , June 2024. - 10 S. : Illustrationen
In: ESMO open, ISSN 2059-7029. 9(2024), 6, Artikel-ID 103466, Seite 1-10
DOI: 10.1016/j.esmoop.2024.103466
Rugo, Hope S.: A plain language summary of the TROPiCS-02 study in patients with breast cancer (HR-positive/HER2-negative) / Hope S Rugo, Aditya Bardia, Frederik Marmé, Javier Cortés, Peter Schmid, Patricia A Spears, Sara M T… , 25 Jan 2024. - 17 S.
In: Future oncology, ISSN 1744-8301. 20(2024), 11, Seite 635-651
DOI: 10.2217/fon-2023-0845
Ledermann, Jonathan A.: ESGO-ESMO-ESP consensus conference recommendations on ovarian cancer : pathology and molecular biology and early, advanced and recurrent disease / J. A. Ledermann, X. Matias-Guiu, F. Amant, N. Concin, B. Davidson, C. Fotopoulou, A. González-Martin… , March 2024. - 19 S. : Illustrationen
In: Annals of oncology, ISSN 1569-8041. 35(2024), 3, Seite 248-266
DOI: 10.1016/j.annonc.2023.11.015
Harter, Philipp: Statement of the AGO Kommission Ovar, AGO Study Group, NOGGO, AGO Austria, Swiss AGO, BGOG, CEEGOG, GEICO, and SFOG regarding the use of hyperthermic intraperitoneal chemotherapy (HIPEC) in epithelial ovarian cancer / Philipp Harter, Gerhard Bogner, Luis Chiva, David Cibula, Nicole Concin, Christina Fotopoulou, Anton… , March 2024. - 8 S.
In: Bulletin du cancer, ISSN 1769-6917. 111(2024), 3, Seite 277-284
DOI: 10.1016/j.bulcan.2023.02.011
Rugo, Hope S.: Health-related quality of life with sacituzumab govitecan in HR+/HER2− metastatic breast cancer in the phase III TROPiCS-02 trial / Hope S Rugo, Peter Schmid, Sara M Tolaney, Florence Dalenc, Frederik Marmé, Ling Shi, Wendy Verret, … , September 2024. - 12 S. : Illustrationen
In: The oncologist, ISSN 1549-490X. 29(2024), 9, Seite 768-779
DOI: 10.1093/oncolo/oyae088
Romey, Marcel: Systematic analysis of homologous recombination deficiency testing in ovarian cancer : development of recommendations for optimal assay performance / Marcel Romey, Fiona Rodepeter, Akira Hattesohl, Kristin Kaiser, Julia Teply-Szymanski, Florian Heitz… , 8 February 2024. - 100445-1-100445-10$t10
In: Modern pathology, ISSN 1530-0285. 37(2024), 4, Artikel-ID 100445
DOI: 10.1016/j.modpat.2024.100445
Colombo, Nicoletta: Atezolizumab and chemotherapy for advanced or recurrent endometrial cancer (AtTEnd) : a randomised, double-blind, placebo-controlled, phase 3 trial / Nicoletta Colombo, Elena Biagioli, Kenichi Harano, Francesca Galli, Emma Hudson, Yoland Antill, Chel… , September 2024. - 12 S. : Illustrationen
In: The lancet, ISSN 1474-5488. 25(2024), 9, Seite 1135-1146
DOI: 10.1016/S1470-2045(24)00334-6
Fasching, Peter Andreas: Prognostic impact of selection criteria of current adjuvant endocrine therapy trials NATALEE and monarchE in postmenopausal HRpos/HER2neg breast cancer patients treated with upfront letrozole / Peter A. Fasching, Carolin C. Hack, Naiba Nabieva, Nicolai Maass, Bahriye Aktas, Sherko Kümmel, Chri… , September 2024. - 10 S. : Diagramm
In: European journal of cancer, ISSN 1879-0852. 209(2024), Artikel-ID 114239, Seite 1-10
DOI: 10.1016/j.ejca.2024.114239
Schröder, Maria: Antikörper-Wirkstoff-Konjugate beim metastasierten Mammakarzinom : eine vielversprechende Behandlungsstrategie : Leitthema / Maria Schröder, Marcus Schmidt, Frederik Marmé, June 2024. - 6 S. : Illustrationen
In: Die Onkologie, ISSN 2731-7234. 30(2024), 6 vom: Juni, Seite 479-484
DOI: 10.1007/s00761-024-01491-5
Jank, Paul: An analysis of PIK3CA hotspot mutations and response to neoadjuvant therapy in patients with breast cancer from four prospective clinical trials / Paul Jank, Thomas Karn, Marion van Mackelenbergh, Judith Lindner, Denise Treue, Jens Huober, Knut En… , 1 September 2024. - 13 S. : Illustrationen
In: Clinical cancer research, ISSN 1557-3265. 30(2024), 17, Seite 3868-3880
DOI: 10.1158/1078-0432.CCR-24-0459
Kabirian, Rayan: TEDOVA: vaccine OSE2101 +/- pembrolizumab as maintenance in platinum-sensitive recurrent ovarian cancer : clinical trial protocol / Rayan Kabirian, Olivier Tredan, Frederik Marmé, Xavier Paoletti, Lauriane Eberst, Coriolan Lebreton,… , 2024. - 10 S. : Illustrationen
In: Future oncology, ISSN 1744-8301. (2024), Seite 1-10
DOI: 10.1080/14796694.2024.2386922
Sinn, Bruno: On-treatment biopsies to predict response to neoadjuvant chemotherapy for breast cancer / Bruno Valentin Sinn, Katharina Sychra, Michael Untch, Thomas Karn, Marion van Mackelenbergh, Jens Hu… , 24 September 2024. - 11 S. : Illustrationen
In: Breast cancer research, ISSN 1465-542X. 26(2024), 1, Seite 1-11
DOI: 10.1186/s13058-024-01883-w
Heublein, Sabine: Fibroblast growth factor receptors and ligands in context of bevacizumab response in ovarian carcinoma : an exploratory analysis of AGO-OVAR11/ICON-7 / Sabine Heublein, Jacobus Pfisterer, Andreas du Bois, Michael Anglesio, Behnaz Aminossadati, Irfan Bh… , April 2024. - 9 S. : Illustrationen
In: Laboratory investigation, ISSN 1530-0307. 104(2024), 4 vom: Apr., Artikel-ID 100321, Seite 1-9
DOI: 10.1016/j.labinv.2023.100321
Massa, Chiara: Baseline CD4+ and expansion of γδ T cells correlate with response to durvalumab in triple-negative breast cancer patients : letter to the journal / Chiara Massa, Thomas Karn, Karsten Weber, Andreas Schneeweiss, Claus Hanusch, Jens Uwe Blohmer, Dirk… , April 2024. - 6 S. : Diagramme
In: Clinical and translational medicine, ISSN 2001-1326. 14(2024), 4 vom: Apr., Artikel-ID e1617, Seite 1-6
DOI: 10.1002/ctm2.1617
Janku, Filip: First-in-human study of naporafenib (LXH254) with or without spartalizumab in adult patients with advanced solid tumors harboring MAPK signaling pathway alterations / Filip Janku, Tae Min Kim, Gopakumar Iyer, Anna Spreafico, Elena Elez, Maja de Jonge, Noboru Yamamoto… , January 2024. - 9 S. : Illustrationen
In: European journal of cancer, ISSN 1879-0852. 196(2024) vom: Jan., Artikel-ID 113458, Seite 1-9
DOI: 10.1016/j.ejca.2023.113458
García-Sáenz, José Angel: Patient-reported outcomes in high-risk HR+/HER2-early breast cancer patients treated with endocrine therapy with or without palbociclib within the randomized PENELOPEB study / Jose Angel Garcia-Saenz, Frederik Marme, Michael Untch, Herve Bonnefoi, Sung-Bae Kim, Harry Bear, Ni… , January 2024. - 7 S.
In: European journal of cancer, ISSN 1879-0852. 196(2024), Artikel-ID 113420, Seite 1-7
DOI: 10.1016/j.ejca.2023.113420
Wildiers, Hans: Paclitaxel plus Eftilagimod Alpha, a soluble LAG-3 protein, in metastatic, HR+ breast cancer : results from AIPAC, a randomized, placebo controlled phase IIb trial / Hans Wildiers, Anne Armstrong, Eveline Cuypere, Florence Dalenc, Luc Dirix, Steve Chan, Frederik Mar… , 1 February 2024. - 10 S. : Illustrationen
In: Clinical cancer research, ISSN 1557-3265. 30(2024), 3 vom: Feb., Seite 532-541
DOI: 10.1158/1078-0432.CCR-23-1173
Jhaveri, Komal: Current and emerging treatment approaches for hormone receptor-positive/human epidermal growth factor receptor 2-negative metastatic breast cancer / Komal Jhaveri, Frederik Marmé, February 2024. - 14 S. : Illustrationen
In: Cancer treatment reviews, ISSN 1532-1967. 123(2024) vom: Feb., Artikel-ID 102670, Seite 1-14
DOI: 10.1016/j.ctrv.2023.102670
Rugo, Hope S.: Overall survival with sacituzumab govitecan in hormone receptor-positive and human epidermal growth factor receptor 2-negative metastatic breast cancer (TROPiCS-02) : a randomised, open-label, multicentre, phase 3 trial / Hope S Rugo, Aditya Bardia, Frederik Marmé, Javier Cortés, Peter Schmid, Delphine Loirat, Olivier Tr… , 21–27 October 2023. - 11 S. : Illustrationen
In: The lancet, ISSN 1474-547X. 402(2023), 10411, Seite 1423-1433
DOI: 10.1016/S0140-6736(23)01245-X
Gonçalves, Juliana P. L.: Characterization of hormone receptor and HER2 status in breast cancer using mass spectrometry imaging / Juliana Pereira Lopes Gonçalves, Christine Bollwein, Aurelia Noske, Anne Jacob, Paul Jank, Sibylle L… , 2 February 2023. - 16 S. : Illustrationen
In: International journal of molecular sciences, ISSN 1422-0067. 24(2023), 3, Artikel-ID 2860, Seite 1-16
DOI: 10.3390/ijms24032860
Wimberger, Pauline: Quality of therapy in early ovarian cancer : results of the quality assurance program of the AGO Study Group / Pauline Wimberger, Jacobus Pfisterer, Andreas du Bois, Felix Hilpert, Markus Kerkmann, Jalid Sehouli… , March 31, 2023. - 7 S.
In: International journal of gynecological cancer, ISSN 1525-1438. 33(2023), 7 vom: Feb., Seite 1083-1089
DOI: 10.1136/ijgc-2022-004233
Marmé, Frederik: Deep learning to predict breast cancer sentinel lymph node status on INSEMA histological images / Frederik Marmé, Eva Krieghoff-Henning, Bernd Gerber, Max Schmitt, Dirk-Michael Zahm, Dirk Bauerschla… , December 2023. - 6 S. : Diagramme
In: European journal of cancer, ISSN 1879-0852. 195(2023), Artikel-ID 113390, Seite 1-6
DOI: 10.1016/j.ejca.2023.113390
Pujade-Lauraine, Éric: Maintenance olaparib rechallenge in patients with platinum-sensitive relapsed ovarian cancer previously treated with a PARP inhibitor (OReO/ENGOT-ov38) : a phase IIIb trial / E. Pujade-Lauraine, F. Selle, G. Scambia, B. Asselain, F. Marmé, K. Lindemann, N. Colombo, R. Mądry,… , December 2023. - 13 S. : Illustrationen
In: Annals of oncology, ISSN 1569-8041. 34(2023), 12 vom: Dez., Seite 1152-1164
DOI: 10.1016/j.annonc.2023.09.3110
Poorebrahim, Mansour: A costimulatory chimeric antigen receptor targeting TROP2 enhances the cytotoxicity of NK cells expressing a T cell receptor reactive to human papillomavirus type 16 E7 / Mansour Poorebrahim, Isaac Quiros-Fernandez, Frederik Marmé, Stefan EG. Burdach, Angel Cid-Arregui, 10 July 2023. - 11 S.
In: Cancer letters, ISSN 1872-7980. 566(2023), Artikel-ID 216242, Seite 1-11
DOI: 10.1016/j.canlet.2023.216242
Williams, Terence M.: Caveolin gene expression predicts clinical outcomes for early-stage HER2-negative breast cancer treated with paclitaxel-based chemotherapy in the GeparSepto trial / Terence M. Williams, Andreas Schneeweiss, Christian Jackisch, Changxian Shen, Karsten E. Weber, Pete… , September 1, 2023. - 11 S. : Illustrationen
In: Clinical cancer research, ISSN 1557-3265. 29(2023), 17, Seite 3384-3394
DOI: 10.1158/1078-0432.CCR-23-0362
Fasching, Peter Andreas: Inferred immune-cell activity is an independent predictor of HER2-negative breast cancer prognosis and response to paclitaxel-based therapy in the GeparSepto trial / Peter A. Fasching, Christopher Szeto, Carsten Denkert, Stephen Benz, Karsten Weber, Patricia Spilman… , 1 July 2023. - 10 S. : Illustrationen
In: Clinical cancer research, ISSN 1557-3265. 29(2023), 13 vom: Juli, Seite 2456-2465
DOI: 10.1158/1078-0432.CCR-22-2213
Sabatier, Renaud: Efficacy and safety of maintenance olaparib and bevacizumab in ovarian cancer patients aged ≥65 years from the PAOLA-1/ENGOT-ov25 trial / Renaud Sabatier, Frédérique Rousseau, Florence Joly, Claire Cropet, Coline Montégut, Johanna Frindte… , March 2023. - 11 S. : Illustrationen
In: European journal of cancer, ISSN 1879-0852. 181(2023) vom: März, Seite 42-52
DOI: 10.1016/j.ejca.2022.11.029
Marmé, Frederik: Antibody-drug conjugates for breast cancer / Frederik Marmé, February 2022. - 11 S.
In: Oncology research and treatment, ISSN 2296-5262. 45(2021), 1-2 vom: Feb., Seite 26-36
DOI: 10.1159/000521499
Galactionova, Katya: Cost-effectiveness of palbociclib in early breast cancer patients with a high risk of relapse : results from the PENELOPE-B trial / Katya Galactionova, Sibylle Loibl, Paola Salari, Frederik Marmé, Miguel Martin, Michael Untch, Hervé… , 05 September 2022. - 13 S.
In: Frontiers in oncology, ISSN 2234-943X. 12(2022), Artikel-ID 886831, Seite 1-13
DOI: 10.3389/fonc.2022.886831
Furlanetto, Jenny: Sacituzumab govitecan: past, present and future of a new antibody-drug conjugate and future horizon : drug evaluation / Jenny Furlanetto, Frederik Marmé and Sibylle Loibl, 7 Sep 2022. - 17 S.
In: Future oncology, ISSN 1744-8301. 18(2022), 28, Seite 3199-3215
DOI: 10.2217/fon-2022-0407
Perez-Garcia, Jose Manuel: Trastuzumab and pertuzumab without chemotherapy in early-stage HER2+ breast cancer : a plain language summary of the PHERGain study / José Manuel Pérez-García, Geraldine Gebhart, Manuel Ruiz Borrego, Peter Schmid, Frederik Marmé, Alei… , 27 Oct 2022. - 12 S. : Illustrationen
In: Future oncology, ISSN 1744-8301. 18(2022), 33 vom: Okt., Seite 3677-3688
DOI: 10.2217/fon-2022-0663
Monk, Bradley J.: A randomized, phase III trial to evaluate rucaparib monotherapy as maintenance treatment in patients with newly diagnosed ovarian cancer (ATHENA-MONO/GOG-3020/ENGOT-ov45) : original reports / Bradley J. Monk, Christine Parkinson, Myong Cheol Lim, David M. O'Malley, Ana Oaknin, Michelle K. Wi… , June 6, 2022. - 29 S.
In: Journal of clinical oncology, ISSN 1527-7755. 40(2022), 34, Seite 3952-3964
DOI: 10.1200/JCO.22.01003
Geyer, Charles Edward <Jr.>: Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer : original article / C.E. Geyer, Jr., J.E. Garber, R.D. Gelber, G. Yothers, M. Taboada, L. Ross, P. Rastogi, K. Cui, A. … , 28 November 2022. - 19 S.
In: Annals of oncology, ISSN 1569-8041. 33(2022), 12 vom: Dez., Seite 1250-1268
DOI: 10.1016/j.annonc.2022.09.159
Denkert, Carsten: Homologous recombination deficiency as an ovarian cancer biomarker in a real-world cohort : validation of decentralized genomic profiling / Carsten Denkert, Marcel Romey, Brad Swedlund, Akira Hattesohl, Julia Teply-Szymanski, Stefan Kommoss… , 30 September 2022. - 10 S.
In: The journal of molecular diagnostics, ISSN 1943-7811. 24(2022), 12 vom: Dez., Seite 1254-1263
DOI: 10.1016/j.jmoldx.2022.09.004
Marmé, Frederik: Olaparib: Präzisionsmedizin beim Pankreas- und Prostatakarzinom : PARP-Inhibition in der onkologischen Praxis / Autoren Prof. Dr. Frederik Marmé, Prof. Dr. Helmut Oettle, Prof. Dr. Martin Schostak, Dr. Ine Schmal… . -
Köln: Deutscher Ärzteverlag GmbH, [2022]. - 11 Seiten : Illustrationen
(Lehre & Praxis. Sonderpublikation)
Merkelbach-Bruse, Sabine: Aktueller Stellenwert des molekularpathologischen Nachweises von DNA-Reparaturdefekten (HRTD bzw. BRCA1/2-Mutationen) für die zielgerichtete Therapie des Ovalrialkarzinoms / Sabine Merkelbach-Bruse und Frederik Marmé. -
Stuttgart: Thieme, Juli 2022. - 15 Seiten : Illustrationen
(Refresher Gynäkologie)
Reinisch, Mattea: Subcutaneous injection of trastuzumab into the thigh versus abdominal wall in patients with HER2-positive early breast cancer : pharmacokinetic, safety and patients' preference : substudy of the randomised phase III GAIN-2 study / Mattea Reinisch, Michael Untch, Rolf Mahlberg, Toralf Reimer, Thomas Hitschold, Frederik Marmé, Must… , [December 2022]. - 8 S. : Diagramme
In: The breast, ISSN 1532-3080. 66(2022) vom: Dez., Seite 110-117
DOI: 10.1016/j.breast.2022.10.002
Leichsenring, Jonas: EVI1 expression in early-stage breast cancer patients treated with neoadjuvant chemotherapy / Jonas Leichsenring, Valentina Vladimirova, Christine Solbach, Thomas Karn, Beyhan Ataseven, Bruno Va… , 05 October 2022. - 10 S. : Illustrationen
In: BMC cancer, ISSN 1471-2407. 22(2022) vom: Okt., Artikel-ID 1040, Seite 1-10
DOI: 10.1186/s12885-022-10109-1
Rugo, Hope S.: Sacituzumab Govitecan in Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer / Hope S. Rugo, Aditya Bardia, Frederik Marmé, Javier Cortes, Peter Schmid, Delphine Loirat, Olivier T… , [2022]. - 12 S. : Diagramme
In: Journal of clinical oncology, ISSN 1527-7755. 40(2022), 29, Seite 3365-3376
DOI: 10.1200/JCO.22.01002
González Martín, Antonio: Maintenance olaparib plus bevacizumab in patients with newly diagnosed advanced high-grade ovarian cancer : main analysis of second progression-free survival in the phase III PAOLA-1/ENGOT-ov25 trial / Antonio González-Martín, Christophe Desauw, Florian Heitz, Claire Cropet, Piera Gargiulo, Regina Ber… , 5 September 2022. - 11 S.
In: European journal of cancer, ISSN 1879-0852. 174(2022), Seite 221-231
DOI: 10.1016/j.ejca.2022.07.022
Llop-Guevara, Alba: Association of RAD51 with homologous recombination deficiency (HRD) and clinical outcomes in untreated triple-negative breast cancer (TNBC) : analysis of the GeparSixto randomized clinical trial / A. Llop-Guevara, S. Loibl, G. Villacampa, V. Vladimirova, A. Schneeweiss, T. Karn, D.-M. Zahm, A. He… , 11 September 2021. - 7 S.
In: Annals of oncology, ISSN 1569-8041. 32(2021), 12 vom: Dez., Seite 1590-1596
DOI: 10.1016/j.annonc.2021.09.003
Schouten, Philip: Ovarian cancer-specific BRCA-like copy-number aberration classifiers detect mutations associated with homologous recombination deficiency in the AGO-TR1 trial / Philip C. Schouten, Lisa Richters, Daniel J. Vis, Stefan Kommoss, Ewald van Dijk, Corinna Ernst, Roe… , September 30, 2021. - 11 S.
In: Clinical cancer research, ISSN 1557-3265. 27(2021), 23, Seite 6559-6569
DOI: 10.1158/1078-0432.CCR-21-1673
Jurmeister, Philipp: DNA methylation profiling identifies two distinct subgroups in breast cancers with low hormone receptor expression, mainly associated with HER2 amplification status / Philipp Jurmeister, Karsten Weber, Sonia Villegas, Thomas Karn, Michael Untch, Anne Thieme, Volkmar … , 03 October 2021. - 10 S.
In: Clinical epigenetics, ISSN 1868-7083. 13(2021), Artikel-ID 184, Seite 1-10
DOI: 10.1186/s13148-021-01176-5
Möbus, Volker: Phase III randomised trial comparing intense dose-dense chemotherapy to tailored dose-dense chemotherapy in high-risk early breast cancer (GAIN-2) / Volker Möbus, Hans-Joachim Lück, Ekkehart Ladda, Peter Klare, Marcus Schmidt, Andreas Schneeweiss, E… , 24 August 2021. - 11 S.
In: European journal of cancer, ISSN 1879-0852. 156(2021), Seite 138-148
DOI: 10.1016/j.ejca.2021.07.033
Denkert, Carsten: Clinical and molecular characteristics of HER2-low-positive breast cancer : pooled analysis of individual patient data from four prospective, neoadjuvant clinical trials / Carsten Denkert, Fenja Seither, Andreas Schneeweiss, Theresa Link, Jens-Uwe Blohmer, Marianne Just, … , July 9, 2021. - 11 S.
In: The lancet, ISSN 1474-5488. 22(2021), 8 vom: Aug., Seite 1151-1161
DOI: 10.1016/S1470-2045(21)00301-6
Perez-Garcia, Jose Manuel: Chemotherapy de-escalation using an 18F-FDG-PET-based pathological response-adapted strategy in patients with HER2-positive early breast cancer (PHERGain) : a multicentre, randomised, open-label, non-comparative, phase 2 trial / José Manuel Pérez-García, Geraldine Gebhart, Manuel Ruiz Borrego, Agostina Stradella, Begoña Bermejo… , May 18, 2021. - 14 S.
In: The lancet, ISSN 1474-5488. 22(2021), 6, Seite 858-871
DOI: 10.1016/S1470-2045(21)00122-4
Furlanetto, Jenny: Chemotherapy-induced ovarian failure in young women with early breast cancer : prospective analysis of four randomised neoadjuvant/adjuvant breast cancer trials / Jenny Furlanetto, Frederik Marmé, Sabine Seiler, Christian Thode, Michael Untch, Sabine Schmatloch, … , 8 June 2021. - 11 S.
In: European journal of cancer, ISSN 1879-0852. 152(2021) vom: Juli, Seite 193-203
DOI: 10.1016/j.ejca.2021.04.038
Loibl, Sibylle: Palbociclib for residual high-risk invasive HR-positive and HER2-negative early breast cancer : the Penelope-B trial / Sibylle Loibl; Frederik Marmé; Miguel Martin; Michael Untch; Hervé Bonnefoi; Sung-Bae Kim; Harry Bea… , April 1, 2021. - 24 S.
In: Journal of clinical oncology, ISSN 1527-7755. 39(2021), 14, Seite 1518-1530
DOI: 10.1200/JCO.20.03639
Villegas, Sonia Lorena: Therapy response and prognosis of patients with early breast cancer with low positivity for hormone receptors : an analysis of 2765 patients from neoadjuvant clinical trials / Sonia L. Villegas, Valentina Nekljudova, Nicole Pfarr, Jutta Engel, Michael Untch, Simone Schrodi, F… , May 2021. - 12 S.
In: European journal of cancer, ISSN 1879-0852. 148(2021) vom: Mai, Seite 159-170
DOI: 10.1016/j.ejca.2021.02.020
Qian, Yuquan: Prognostic cancer gene expression signatures : current status and challenges / Yuquan Qian, Jimmy Daza, Timo Itzel, Johannes Betge, Tianzuo Zhan, Frederik Marmé and Andreas Teufel, 15 March 2021. - 17 S.
In: Cells, ISSN 2073-4409. 10(2021), 3, Artikel-ID 648, Seite 1-17
DOI: 10.3390/cells10030648
Sinn, Bruno: Immune-related gene expression predicts response to neoadjuvant chemotherapy but not additional benefit from PD-L1 inhibition in women with early triple-negative breast cancer / Bruno V. Sinn, Sibylle Loibl, Claus A. Hanusch, Dirk-Michael Zahm, Hans-Peter Sinn, Michael Untch, K… , February 16, 2021. - 9 S.
In: Clinical cancer research, ISSN 1557-3265. 27(2021), 9 vom: Mai, Seite 2584-2591
DOI: 10.1158/1078-0432.CCR-20-3113
Bergmeister-Berghoff, Anna Sophie: Identification and characterization of cancer cells that initiate metastases to the brain and other organs / Anna S. Berghoff, Yunxiang Liao, Matthia A. Karreman, Ayseguel Ilhan-Mutlu, Katharina Gunkel, Martin… , 2021. - 14 S.
In: Molecular cancer research, ISSN 1557-3125. 19(2021), 4 vom: Apr., Seite 688-701
DOI: 10.1158/1541-7786.MCR-20-0863
Denkert, Carsten: Reconstructing tumor history in breast cancer : signatures of mutational processes and response to neoadjuvant chemotherapy⋆ / C. Denkert, M. Untch, S. Benz, A. Schneeweiss, K.E. Weber, S. Schmatloch, C. Jackisch, H.P. Sinn, J.… , 6 January 2021. - 12 S.
In: Annals of oncology, ISSN 1569-8041. 32(2021), 4, Seite 500-511
DOI: 10.1016/j.annonc.2020.12.016
Mavratzas, Athanasios: Alpelisib in the treatment of metastatic HR+ breast cancer with PIK3CA mutations / Athanasios Mavratzas, Frederik Marmé, 23 Sep 2020. - 14 S.
In: Future oncology, ISSN 1744-8301. 17(2020), 1, Seite 13-36
DOI: 10.2217/fon-2020-0464
Karn, Thomas: A small hypoxia signature predicted pCR response to bevacizumab in the neoadjuvant GeparQuinto breast cancer trial / Thomas Karn, Tobias Meissner, Karsten E. Weber, Christine Solbach, Carsten Denkert, Knut Engels, Pet… , January 13, 2020. - 9 S.
In: Clinical cancer research, ISSN 1557-3265. 26(2020), 8 vom: Apr., Seite 1896-1904
DOI: 10.1158/1078-0432.CCR-19-1954
Rüger, Alexandra Maria: Cardiotoxicity and cardiovascular biomarkers in patients with breast cancer : data from the GeparOcto‐GBG 84 trial / Alexandra Maria Rüger, MPH; Andreas Schneeweiss, MD, PhD; Sabine Seiler, MD; Hans Tesch, MD, PhD; Ma… , 16 Nov 2020. - 13 S.
In: Journal of the American Heart Association, ISSN 2047-9980. 9(2020), 23, Artikel-ID e018143, Seite 1-13
DOI: 10.1161/JAHA.120.018143
Massa, Chiara: Differential effect on different immune subsets of neoadjuvant chemotherapy in patients with TNBC / Chiara Massa, Thomas Karn, Carsten Denkert, Andreas Schneeweiss, Claus Hanusch, Jens-Uwe Blohmer, Di… , 16 November 2020. - 11 S. : Diagramme
In: Journal for ImmunoTherapy of Cancer, ISSN 2051-1426. 8(2020,2) Artikel-Nummer e001261, 11 Seiten
DOI: 10.1136/jitc-2020-001261
Lindner, Thomas: Design and development of 99mTc-labeled FAPI tracers for SPECT imaging and 188Re therapy / Thomas Lindner, Annette Altmann, Susanne Krämer, Christian Kleist, Anastasia Loktev, Clemens Kratoch… , März 13, 2020. - 8 S.
In: Journal of nuclear medicine, ISSN 2159-662X. 61(2020), 10, Seite 1507-1513
DOI: 10.2967/jnumed.119.239731
Jank, Paul: MGMT promoter methylation in triple negative breast cancer of the GeparSixto trial / Paul Jank, Claire Gehlhaar, Lederer Bianca, Fontanella Caterina, Schneeweiss Andreas, Thomas Karn, F… , August 25, 2020. - 12 S.
In: PLOS ONE, ISSN 1932-6203. 15(2020,8) Artikel-Nummer 0238021, 12 Seiten
DOI: 10.1371/journal.pone.0238021
Karn, Thomas: Tumor mutational burden and immune infiltration as independent predictors of response to neoadjuvant immune checkpoint inhibition in early TNBC in GeparNuevo / T. Karn, C. Denkert, K. E. Weber, U. Holtrich, C. Hanusch, B. V. Sinn, B. W. Higgs, P. Jank, H. P. S… , 24 May 2020. - 7 S. : Diagramme
In: Annals of oncology, ISSN 1569-8041. 31(2020), 9, Seite 1216-1222
DOI: 10.1016/j.annonc.2020.05.015
Maier, Anna: Prediction of pathological complete response in breast cancer patients during neoadjuvant chemotherapy : is shear wave elastography a useful tool in clinical routine? / Anna Marie Maier, Jörg Heil, Aba Harcos, Hans-Peter Sinn, Geraldine Rauch, Lorenz Uhlmann, Christina… , 1 May 2020. - 10 S.
In: European journal of radiology, ISSN 1872-7727. 128(2020) Artikel-Nummer 109025, 10 Seiten
DOI: 10.1016/j.ejrad.2020.109025
Müller, Martin: Preclinical evaluation of peptide-based radiotracers for integrin αvβ6-positive pancreatic carcinoma / authors: Martin Müller, Annette Altmann, Max Sauter, Thomas Lindner, Dirk Jäger, Hendrik Rathke, Chr… , 10. Mai 2019. - 10 S.
In: Nuklearmedizin, ISSN 2567-6407. 58(2019), 4, Seite 309-318
DOI: 10.1055/a-0894-4127
Sinn, Bruno: Human leucocyte antigen class I in hormone receptor-positive, HER2-negative breast cancer : association with response and survival after neoadjuvant chemotherapy / Bruno Valentin Sinn, Karsten E. Weber, Wolfgang Daniel Schmitt, Peter A. Fasching, William Fraser Sy… , 11 December 2019. - 9 S.
In: Breast cancer research, ISSN 1465-542X. 21(2019), Artikel-ID 142, Seite 1-9
DOI: 10.1186/s13058-019-1231-z
Hauke, Jan: Deleterious somatic variants in 473 consecutive individuals with ovarian cancer : results of the observational AGO-TR1 study (NCT02222883) / Jan Hauke, Eric Hahnen, Stephanie Schneider, Alexander Reuss, Lisa Richters, Stefan Kommoss, André H… , 12 April 2019. - 7 S.
In: Journal of medical genetics, ISSN 1468-6244. 56(2019), 9, Seite 574-580
DOI: 10.1136/jmedgenet-2018-105930
Witzel, Isabell: Androgen receptor expression and response to chemotherapy in breast cancer patients treated in the neoadjuvant TECHNO and PREPARE trial / Isabell Witzel, Sibylle Loibl, Ralph Wirtz, Peter A. Fasching, Carsten Denkert, Karsten Weber, Hans-… , 15 November 2019. - 7 S.
In: British journal of cancer, ISSN 1532-1827. 121(2019), 12, Seite 1009-1015
DOI: 10.1038/s41416-019-0630-3
Forster, Tobias: Second breast conserving therapy after ipsilateral breast tumor recurrence - a 10-year experience of re-irradiation / Tobias Forster, Sati Akbaba, Daniela Schmitt, David Krug, Rami El Shafie, Jan Oelmann-Avendano, Katj… , 2019/08/22. - 8 S.
In: Journal of contemporary brachytherapy, ISSN 2081-2841. 11(2019), 4, Seite 312-319
DOI: 10.5114/jcb.2019.87001
Heublein, Sabine: Fibroblast growth factor receptor 4 (FGFR4) as detected by immunohistochemistry is associated with postoperative residual disease in ovarian cancer / Sabine Heublein, Michael S. Anglesio, Frederik Marmé, Stefan Kommoss, 5 August 2019. - 9 S.
In: Journal of cancer research and clinical oncology, ISSN 1432-1335. 145(2019), 9, Seite 2251-2259
DOI: 10.1007/s00432-019-02986-0
Loktev, Anastasia: Development of fibroblast activation protein-targeted radiotracers with improved tumor retention / Anastasia Loktev, Thomas Lindner, Eva-Maria Burger, Annette Altmann, Frederik Giesel, Clemens Kratoc… , March 8, 2019. - 9 S.
In: Journal of nuclear medicine, ISSN 2159-662X. 60(2019), 10, Seite 1421-1429
DOI: 10.2967/jnumed.118.224469
Heublein, Sabine: Extracapsular lymph node involvement in ovarian carcinoma / Sabine Heublein, Heiko Schulz, Frederik Marmé, Martin Angele, Bastian Czogalla, Alexander Burges, Sv… , 1 July 2019. - 13 S.
In: Cancers, ISSN 2072-6694. 11(2019,7) Artikel-Nummer 924, 13 Seiten
DOI: 10.3390/cancers11070924
Michel, Laura L.: Prediction of local recurrence risk after neoadjuvant chemotherapy in patients with primary breast cancer : clinical utility of the MD Anderson Prognostic Index / Laura L. Michel, Laura Sommer, Rosa González Silos, Justo Lorenzo Bermejo, Alexandra von Au, Julia S… , January 31, 2019. - 11 S.
In: PLOS ONE, ISSN 1932-6203. 14(2019,1) Artikel-Nummer e0211337, 11 Seiten
DOI: 10.1371/journal.pone.0211337
Michel, Laura L.: Locoregional risk assessment after neoadjuvant chemotherapy in patients with primary breast cancer : clinical utility of the CPS + EG score / Laura L. Michel, Laura Sommer, Rosa González Silos, Justo Lorenzo Bermejo, Alexandra von Au, Julia S… , 24 June 2019. - 10 S.
In: Breast cancer research and treatment, ISSN 1573-7217. 177(2019), 2, Seite 437-446
DOI: 10.1007/s10549-019-05314-9
Huober, Jens: Luminal metastatic breast cancer / Jens Huober, Rupert Bartsch, Frederik Marmé, Olivia Pagani, Christoph Thomssen, April 9, 2019. - 3 S.
In: Breast care, ISSN 1661-3805. 14(2019), 2, Seite 99-101
DOI: 10.1159/000499440
Salzmann, Martin: Prophylaxis and management of skin toxicities / Martin Salzmann, Frederik Marmé, Jessica C. Hassel, 2019. - 6 S.
In: Breast care, ISSN 1661-3805. 14(2019), 2, Seite 72-77
DOI: 10.1159/000497232
Mavratzas, Athanasios: Sorafenib in combination with docetaxel as first-line therapy for HER2-negative metastatic breast cancer : final results of the randomized, double-blind, placebo-controlled phase II MADONNA study / A. Mavratzas, S. Baek, B. Gerber, M. Schmidt, V. Moebus, F. Foerster, E.M. Grischke, P. Fasching, D.… , 13 February 2019. - 7 S.
In: The breast, ISSN 1532-3080. 45(2019), Seite 22-28
DOI: 10.1016/j.breast.2019.02.002
Smetanay, Katharina: COOLHAIR : a prospective randomized trial to investigate the efficacy and tolerability of scalp cooling in patients undergoing (neo)adjuvant chemotherapy for early breast cancer / Katharina Smetanay, Philippe Junio, Manuel Feißt, Julia Seitz, Jessica Cecile Hassel, Luisa Mayer, L… , 2019. - 9 S.
In: Breast cancer research and treatment, ISSN 1573-7217. 173(2019), 1, Seite 135-143
DOI: 10.1007/s10549-018-4983-8
Fremd, Carlo: Mismatch repair deficiency drives durable complete remission by targeting programmed death receptor 1 in a metastatic luminal breast cancer patient / Carlo Fremd, Mario Hlevnjak, Marc Zapatka, Inka Zoernig, Niels Halama, Nino Fejzibegovic, Verena The… , 2019. - 7 S.
In: Breast care, ISSN 1661-3805. 14(2019), 1, Seite 53-59
DOI: 10.1159/000492580
Bischoff, Joachim: A randomized phase II study to determine the efficacy and tolerability of two doses of eribulin plus lapatinib in trastuzumab-pretreated patients with HER-2-positive metastatic breast cancer (E-VITA) / Joachim Bischoff, Jana Barinoff, Christoph Mundhenke, Dirk O. Bauerschlag, Serban-Dan Costa, Daniel … , APR 2019. - 8 S.
In: Anti-cancer drugs, ISSN 1473-5741. 30(2019), 4, Seite 394-401
DOI: 10.1097/CAD.0000000000000722
Marmé, Frederik: Medikamentöse Therapie des Ovarialkarzinoms in der Primär- und Rezidivsituation : = / Frederik Marmé, Philipp Harter, Beyhan Ataseven, 14. Januar 2019. - 14 S.
In: Der Onkologe, ISSN 1433-0415. 25(2019), 2, Seite 131-144
DOI: 10.1007/s00761-018-0511-z
Marmé, Frederik: Therapieoptionen zum Ovarialkarzinom / Frederik Marmé. - 2 S.
In: Der Onkologe, ISSN 1433-0415. 25(2019), 2, S. 90-91
DOI: 10.1007/s00761-019-0523-3
Heublein, Sabine: Potential interplay of the Gatipotuzumab epitope TA-MUC1 and estrogen receptors in ovarian cancer / Sabine Heublein, Sabina Page, Doris Mayr, Elisa Schmoeckel, Fabian Trillsch, Frederik Marmé, Sven Ma…
In: International journal of molecular sciences, ISSN 1422-0067. 20(2019,2) Artikel-Nummer 295, 14 Seiten
DOI: 10.3390/ijms20020295
Pivot, Xavier: Subgroup analysis of patients with HER2-negative metastatic breast cancer in the second-line setting from a phase 3, open-label, randomized study of eribulin mesilate versus capecitabine / Xavier Pivot, Seock Ah Im, Matthew Guo, Frederik Marmé, 4 January 2018. - 5 S.
In: Breast cancer, ISSN 1880-4233. 25(2018), 3, Seite 370-374
DOI: 10.1007/s12282-017-0826-4
Stevic, Ines: Specific microRNA signatures in exosomes of triple-negative and HER2-positive breast cancer patients undergoing neoadjuvant therapy within the GeparSixto trial / Ines Stevic, Volkmar Müller, Karsten Weber, Peter A. Fasching, Thomas Karn, Frederic Marmé, Christia… , 10. October 2018. - 16 S.
In: BMC medicine, ISSN 1741-7015. 16(2018) Artikel-Nummer 179, 16 Seiten
DOI: 10.1186/s12916-018-1163-y
Schneeweiss, Andreas: Phase Ib study evaluating safety and clinical activity of the anti-HER3 antibody lumretuzumab combined with the anti-HER2 antibody pertuzumab and paclitaxel in HER3-positive, HER2-low metastatic breast cancer / Andreas Schneeweiss, Tjoung-Won Park-Simon, Joan Albanell, Ulrik Lassen, Javier Cortés, Veronique Di… , 19 January 2018. - 12 S.
In: Investigational new drugs, ISSN 1573-0646. 36(2018), 5, Seite 848-859
DOI: 10.1007/s10637-018-0562-4
Mackelenbergh, Marion Tina van: Outcome after neoadjuvant chemotherapy in estrogen receptor-positive and progesterone receptor-negative breast cancer patients : a pooled analysis of individual patient data from ten prospectively randomized controlled neoadjuvant trials / Marion T. van Mackelenbergh, Carsten Denkert, Valentina Nekljudova, Thomas Karn, Christian Schem, Fr… , 2018. - 13 S.
In: Breast cancer research and treatment, ISSN 1573-7217. 167(2018), 1, Seite 59-71
DOI: 10.1007/s10549-017-4480-5
Loibl, Sibylle: Risk assessment after neoadjuvant chemotherapy in luminal breast cancer using a clinicomolecular predictor / Sibylle Loibl, Karsten Weber, Jens Huober, Kristin Krappmann, Frederik Marmé, Christian Schem, Knut … , April 4, 2018. - 8 S.
In: Clinical cancer research, ISSN 1557-3265. 24(2018), 14, Seite 3358-3365
DOI: 10.1158/1078-0432.CCR-17-2947
Heublein, Sabine: TA-MUC1 as detected by the fully humanized, therapeutic antibody Gatipotzumab predicts poor prognosis in cervical cancer / Sabine Heublein, Klaus Friese, Bernd Kost, Frederik Marmé, Christina Kuhn, Sven Mahner, Christian Da… , 30 July 2018. - 9 S.
In: Journal of cancer research and clinical oncology, ISSN 1432-1335. 144(2018), 10, Seite 1899-1907
DOI: 10.1007/s00432-018-2706-5
Marmé, Frederik: Phase 1, open-label, dose-escalation study of sorafenib in combination with eribulin in patients with advanced, metastatic, or refractory solid tumors / Frederik Marmé, Carlos Gomez-Roca, Kristina Graudenz, Funan Huang, John Lettieri, Carol Peña, Zuzana… , [April 2018]. - 11 S. : Diagramme
In: Cancer chemotherapy and pharmacology, ISSN 1432-0843. 81(2018), 4, Seite 727-737
DOI: 10.1007/s00280-018-3540-9
Seitz, Julia: Mammakarzinom in der Schwangerschaft / J. Seitz, A. von Au, C. Sohn, F. Marme, A. Schneeweiss, 25 April 2018. - 6 S.
In: Der Onkologe, ISSN 1433-0415. 24(2018), 7, Seite 539-544
DOI: 10.1007/s00761-018-0376-1
Schütz, Florian: Immunooncology in breast cancer : active and passive vaccination strategies / Florian Schütz, Frederik Marmé, Christoph Domschke, Christof Sohn, Alexandra von Au, January 31, 2018. - 5 S.
In: Breast care, ISSN 1661-3805. 13(2018), 1, Seite 22-26
DOI: 10.1159/000486330
Schmalfeldt, Barbara: What is the evidence for lymphadenectomy in presumed early ovarian cancer? / Barbara Schmalfeldt, Christine Brambs, Alexander Burges, Ahmed El-Balat, Günter Emons, Daniel Fink, … , 2019. - 5 S.
In: Archives of gynecology and obstetrics, ISSN 1432-0711. 299(2019), 1, Seite 1-5
DOI: 10.1007/s00404-018-4945-8
Hadji, Peyman: The impact of mammalian target of rapamycin inhibition on bone health in postmenopausal women with hormone receptor-positive advanced breast cancer receiving everolimus plus exemestane in the phase IIIb 4EVER trial / Peyman Hadji, Oliver Stoetzer, Thomas Decker, Christian M. Kurbacher, Frederik Marmé, Andreas Schnee… , 2019. - 9 S.
In: Journal of bone oncology, ISSN 2212-1374. 14(2019) Artikel-Nummer 100199, 9 Seiten
DOI: 10.1016/j.jbo.2018.09.010
Weber-Lassalle, Konstantin: Diagnosis of Li-Fraumeni syndrome : Differentiating TP53 germline mutations from clonal hematopoiesis : Results of the observational AGO-TR1 trial / Konstantin Weber-Lassalle, Philipp Harter, Jan Hauke, Corinna Ernst, Stefan Kommoss, Frederik Marmé,… , 14 September 2018. - 7 S.
In: Human mutation, ISSN 1098-1004. 39(2018), 12, Seite 2040-2046
DOI: 10.1002/humu.23653
Jauch, Sarah: Sustained prognostic impact of circulating tumor cell status and kinetics upon further progression of metastatic breast cancer / Sarah F. Jauch, Sabine Riethdorf, Martin R. Sprick, Florian Schütz, Birgitt Schönfisch, Sara Y. Bruc… , 2019. - 11 S.
In: Breast cancer research and treatment, ISSN 1573-7217. 173(2019), 1, Seite 155-165
DOI: 10.1007/s10549-018-4972-y
Au, Alexandra von: Zervixkarzinom in der Schwangerschaft : = / A. von Au, A. Schneeweiss, J. Seitz, C. Sohn, J. Rom, F. Marmé, 09 April 2018. - 6 S.
In: Der Onkologe, ISSN 1433-0415. 24(2018), 7, Seite 528-533
DOI: 10.1007/s00761-018-0368-1
Tesch, Hans: Efficacy and safety of everolimus plus exemestane in postmenopausal women with hormone receptor-positive, human epidermal growth factor receptor 2-negative locally advanced or metastatic breast cancer : Results of the single-arm, phase IIIB 4EVER trial / Hans Tesch, Oliver Stoetzer, Thomas Decker, Christian M. Kurbacher, Frederik Marmé, Andreas Schneewe… , 2019. - 9 S.
In: International journal of cancer, ISSN 1097-0215. 144(2019), 4, Seite 877-885
DOI: 10.1002/ijc.31738
Friese, Klaus: The G protein-coupled estrogen receptor (GPER/GPR30) may serve as a prognostic marker in early-stage cervical cancer / Klaus Friese, Bernd Kost, Aurelia Vattai, Frederik Marmé, Christina Kuhn, Sven Mahner, Christian Dan… , 2018. - 7 S.
In: Journal of cancer research and clinical oncology, ISSN 1432-1335. 144(2018), 1, Seite 13-19
DOI: 10.1007/s00432-017-2510-7
Ettl, Johannes: CDK4/6 inhibitors in the treatment of metastatic breast cancer / Chair: Johannes Ettl, Paricipants: Jens Huober, Diana Lüftner, Frederik Marmé, Rachel Würstlein. - 3 S.
In: Breast care, ISSN 1661-3805. 12(2017), 2, S. 118-120
DOI: 10.1159/000475541
Rossum, Annelot van: BRCA1-like profile is not significantly associated with survival benefit of non-myeloablative intensified chemotherapy in the GAIN randomized controlled trial / A.G.J. van Rossum, P.C. Schouten, K.E. Weber, V. Nekljudova, C. Denkert, C. Solbach, C.H. Köhne, C. … . - 11 S.
In: Breast cancer research and treatment, ISSN 1573-7217. 166(2017), 3, S. 775-785
DOI: 10.1007/s10549-017-4444-9
Villegas, Sonia Lorena: Expression of Cyclin D1 protein in residual tumor after neoadjuvant chemotherapy for breast cancer / S.L. Villegas, S. Darb-Esfahani, G. von Minckwitz, J. Huober, K. Weber, F. Marmé, J. Furlanetto, C. … . - 9 S.
In: Breast cancer research and treatment, ISSN 1573-7217. 168(2018), 1, S. 179-187
DOI: 10.1007/s10549-017-4581-1
Harter, Philipp: Prevalence of deleterious germline variants in risk genes including BRCA1/2 in consecutive ovarian cancer patients (AGO-TR-1) / Philipp Harter, Jan Hauke, Florian Heitz, Alexander Reuss, Stefan Kommoss, Frederik Marmé, André Hei…
In: PLOS ONE, ISSN 1932-6203. 12(2017,10) Artikel-Nummer e0186043, 12 Seiten
DOI: 10.1371/journal.pone.0186043
Yang, Rongxi: The association between breast cancer and S100P methylation in peripheral blood by multicenter case-control studies / Rongxi Yang, Sarah Stöcker, Sarah Schott, Jörg Heil, Frederik Marme, Katarina Cuk, Bowang Chen, Mich… , 2017. - 9 S.
In: Carcinogenesis, ISSN 1460-2180. 38(2017), 3, Seite 312-320
DOI: 10.1093/carcin/bgx004
Surowy, Harald: A low-frequency haplotype spanning SLX4/FANCP constitutes a new risk locus for early-onset breast cancer (<60 years) and is associated with reduced DNA repair capacity / Harald Surowy, Dominic Varga, Barbara Burwinkel, Frederik Marmé, Christof Sohn, Manuel Luedeke, Antj… . - 12 S.
In: International journal of cancer, ISSN 1097-0215. 142(2017), 4, S. 757-768
DOI: 10.1002/ijc.31105
Dinkic, Christine: Pazopanib (GW786034) and cyclophosphamide in patients with platinum-resistant, recurrent, pre-treated ovarian cancer : results of the PACOVAR-trial / C. Dinkic, M. Eichbaum, M. Schmidt, E.M. Grischke, G. Gebauer, H.C. Fricke, F. Lenz, M. Wallwiener, … . - 6 S.
In: Gynecologic oncology, ISSN 1095-6859. 146(2017), 2, S. 279-284
DOI: 10.1016/j.ygyno.2017.05.013
Guo, Qi: Body mass index and breast cancer survival : a Mendelian randomization analysis / Qi Guo, Stephen Burgess, Constance Turman, Manjeet K. Bolla, Qin Wang, Michael Lush, Jean Abraham, K… , 9 October 2017. - 9 S.
In: International journal of epidemiology, ISSN 1464-3685. 46(2017), 6, Seite 1814-1822
DOI: 10.1093/ije/dyx131
Köllensperger, Eva: The impact of human adipose tissue-derived stem cells on breast cancer cells: implications for cell-assisted lipotransfers in breast reconstruction / Eva Köllensperger; Lilly-Claire Bonnert; Inka Zörnig; Frederik Marmé; Stefanie Sandmann; Günter Germ… . -
London: BioMed Central, 2017. - 1 Online-Ressource
DOI: 10.1186/s13287-017-0579-1
Shimelis, Hermela: BRCA2 hypomorphic missense variants confer moderate risks of breast cancer / Hermela Shimelis, Romy L.S. Mesman, Catharina Von Nicolai, Asa Ehlen, Lucia Guidugli, Charlotte Mart… , June 2017. - 11 S.
In: Cancer research, ISSN 1538-7445. 77(2017), 11, Seite 2789-2799
DOI: 10.1158/0008-5472.CAN-16-2568
Muranen, Taru A.: Genetic modifiers of CHEK2*1100delC-associated breast cancer risk / Taru A. Muranen, Dario Greco, Carl Blomqvist, Kristiina Aittomäki, Sofia Khan, Frans Hogervorst, Sen… , 2017. - 5 S.
In: Genetics in medicine, ISSN 1530-0366. 19(2017), 5, Seite 599-603
DOI: 10.1038/gim.2016.147
Sinn, Peter: Comparison of immunohistochemistry with PCR for assessment of ER, PR, and Ki-67 and prediction of pathological complete response in breast cancer / Hans-Peter Sinn, Andreas Schneeweiss, Marius Keller, Kornelia Schlombs, Mark Laible, Julia Seitz, So…
In: BMC cancer, ISSN 1471-2407. 17(2017) Artikel-Nummer 124, 10 Seiten
DOI: 10.1186/s12885-017-3111-1
Sinn, Peter: Comparison of immunohistochemistry with PCR for assessment of ER, PR, and Ki-67 and prediction of pathological complete response in breast cancer / Hans-Peter Sinn, Andreas Schneeweiss, Marius Keller, Kornelia Schlombs, Mark Laible, Julia Seitz, So… . -
London; Berlin; Heidelberg: BioMed Central; Springer, 13 February 2017. - 1 Online-Ressource (10 Seiten)
DOI: 10.1186/s12885-017-3111-1
Untch, Michael: ABC3 consensus commented from the perspective of the German guidelines : third International Consensus Conference for Advanced Breast Cancer (ABC3),Lisbon, 07.11.2015 / M. Untch, D. Augustin, J. Ettl, R. Haidinger, N. Harbeck, H.-J. Lück, D. Lüftner, F. Marmé, L. Mülle… , 29. Februar 2016. - 8 S.
In: Geburtshilfe und Frauenheilkunde, ISSN 1438-8804. 76(2016), 2, Seite 156-163
DOI: 10.1055/s-0042-101168
Peng, Cike: Plasma S100P level as a novel prognostic marker of metastatic breast cancer / Cike Peng, Hongda Chen, Markus Wallwiener, Caroline Modugno, Katarina Cuk, Dharanija Madhavan, Andre… , 04 May 2016. - 10 S.
In: Breast cancer research and treatment, ISSN 1573-7217. 157(2016), 2, Seite 329-338
DOI: 10.1007/s10549-016-3776-1
Marmé, Frederik: Utility of the CPS + EG staging system in hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer treated with neoadjuvant chemotherapy / Frederik Marmé, Bianca Lederer, Jens-Uwe Blohmer, Serban Dan Costa, Carsten Denkert, Holger Eidtmann… , 2016. - 10 S.
In: The European journal of cancer, ISSN 0959-8049. 53(2016), Seite 65-74
Gluz, Oleg: Therapy standards in HER2-positive breast cancer / Oleg Gluz, Cornelia Liedtke, Frederik Marmé, Marc Thill, April 26, 2016. - 3 S.
In: Breast care, ISSN 1661-3805. 11(2016), 2, Seite 148-150
DOI: 10.1159/000445965
Thomssen, Christoph: ABC3 consensus : assessment by a german group of experts / Christoph Thomssen, Doris Augustin, Johannes Ettl, Renate Haidinger, Hans-Joachim Lück, Diana Lüftne… , February 2016. - 10 S.
In: Breast care, ISSN 1661-3805. 11(2016), 1, Seite 61-70
DOI: 10.1159/000443515
Schouten, Philip: BRCA1-like profile predicts benefit of tandem high dose epirubicin-cyclophospamide-thiotepa in high risk breast cancer patients randomized in the WSG-AM01 trial / Philip C. Schouten, Oleg Gluz, Nadia Harbeck, Svjetlana Mohrmann, Raihana Diallo‐Danebrock, Enrico P… , 3 Mar 2016. - 8 S.
In: International journal of cancer, ISSN 1097-0215. 139(2016), 4, Seite 882-889
DOI: 10.1002/ijc.30078
Bashari, Muhammad Hasan: Mcl-1 confers protection of Her2-positive breast cancer cells to hypoxia : therapeutic implications / Muhammad Hasan Bashari, Fengjuan Fan, Sonia Vallet, Martin Sattler, Melissa Arn, Claudia Luckner-Min… , 26 February 2016. - 15 S.
In: Breast cancer research, ISSN 1465-542X. 18(2016), Artikel-ID 26, Seite 1-15
DOI: 10.1186/s13058-016-0686-4
Marmé, Frederik: Immunotherapy in breast cancer / Frederik Marmé, May 25, 2016. - 11 S.
In: Oncology research and treatment, ISSN 2296-5262. 39(2016), 6, Seite 335-345
DOI: 10.1159/000446340
González Martín, Antonio: Pertuzumab plus chemotherapy for platinum-resistant ovarian cancer : safety run-in results of the PENELOPE trial / Antonio González-Martín, MD, Patricia Pautier, MD, Sven Mahner, MD, Joern Rau, MSc, Nicoletta Colomb… , 2016. - 7 S.
In: International journal of gynecological cancer, ISSN 1525-1438. 26(2016), 5, Seite 898-905
DOI: 10.1097/IGC.0000000000000695
Hänse, Nicole: A phase I trial of the trifunctional anti Her2 × anti CD3 antibody ertumaxomab in patients with advanced solid tumors / N. Haense, A. Atmaca, C. Pauligk, K. Steinmetz, F. Marmé, G.M. Haag, M. Rieger, O.G. Ottmann, P. Ruf… , 07 July 2016. - 10 S.
In: BMC cancer, ISSN 1471-2407. 16(2016) Artikel-Nummer 420, 10 Seiten
DOI: 10.1186/s12885-016-2449-0
Kurzeder, Christian: Double-blind, placebo-controlled, randomized phase III trial evaluating pertuzumab combined with chemotherapy for low tumor human epidermal growth factor receptor 3 mRNA-expressing platinum-resistant ovarian cancer (PENELOPE) / Christian Kurzeder, Isabel Bover, Frederik Marmé, Joern Rau, Patricia Pautier, Nicoletta Colombo, Do… . - 10 S.
In: Journal of clinical oncology, ISSN 1527-7755. 34(2016), 21, S. 2516-2525
DOI: 10.1200/JCO.2015.66.0787
Pivot, Xavier: Pooled analyses of eribulin in metastatic breast cancer patients with at least one prior chemotherapy / X. Pivot, F. Marmé, R. Koenigsberg, M. Guo, E. Berrak & A. Wolfer. - 7 S.
In: Annals of oncology, ISSN 1569-8041. 27(2016), 8, S. 1525-1531
DOI: 10.1093/annonc/mdw203
Tang, Qiuqiong: DNA methylation array analysis identifies breast cancer associated RPTOR , MGRN1 and RAPSN hypomethylation in peripheral blood DNA / Qiuqiong Tang, Tim Holland-Letz, Alla Slynko, Katarina Cuk, Frederik Marme, Sarah Schott, Jörg Heil,… , 26 August 2016. - 12 S.
In: OncoTarget, ISSN 1949-2553. 7(2016), 39, Seite 64191-64202
DOI: 10.18632/oncotarget.11640
Bischoff, Joachim: A randomized phase II study to determine the efficacy and tolerability of two doses of eribulin plus lapatinib in trastuzumab pre-treated patients with Her2-positive metastatic breast cancer - E-Vita - / J. Bischoff, J. Barinoff, C. Mundhenke, D. Bauerschlag, S.D. Costa, D. Herr, K. Lübe, F. Marmé, N. M…
In: Annals of oncology, ISSN 1569-8041. 27(2016,Supplement 6) Artikel-Nummer 273P,1 Seite
DOI: 10.1093/annonc/mdw365.52
Furlanetto, Jenny: Higher rate of severe toxicities in obese patients receiving dose-dense (dd) chemotherapy according to unadjusted body surface area : results of the prospectively randomized GAIN study / J. Furlanetto, W. Eiermann, F. Marmé, T. Reimer, M. Reinisch, S. Schmatloch, E. Stickeler, C. Thomss… , 8 August 2016. - 7 S.
In: Annals of oncology, ISSN 1569-8041. 27(2016), 11, Seite 2053-2059
DOI: 10.1093/annonc/mdw315
Marmé, Frederik: Phase 1 study of sorafenib and eribulin in patients with advanced, metastatic or refractory solid tumors / F. Marmé, C. Gomez-Roca, K. Graudenz, F. Huang, J. Lettieri, C. Pena, Z. Trnkova, J. Eucker. - 22 S.
In: Annals of oncology, ISSN 1569-8041. 27(2016), Supplement 6, S. vi114-vi135
DOI: 10.1093/annonc/mdw368.40
Hennigs, André: Changes in chemotherapy usage and outcome of early breast cancer patients in the last decade / A. Hennigs, F. Riedel, F. Marmé, P. Sinn, K. Lindel, A. Gondos, K. Smetanay, M. Golatta, C. Sohn, F.… , 15 October 2016. - 9 S.
In: Breast cancer research and treatment, ISSN 1573-7217. 160(2016), 3, Seite 491-499
DOI: 10.1007/s10549-016-4016-4
Wyszynski, Asaf: An intergenic risk locus containing an enhancer deletion in 2q35 modulates breast cancer risk by deregulating IGFBP5 expression / Asaf Wyszynski, Chi-Chen Hong, Kristin Lam, Kyriaki Michailidou, Christian Lytle, Song Yao, Yali Zha… , July 11, 2016. - 14 S.
In: Human molecular genetics, ISSN 1460-2083. 25(2016), 17, Seite 3863-3876
DOI: 10.1093/hmg/ddw223
Hamdi, Yosr: Association of breast cancer risk with genetic variants showing differential allelic expression : identification of a novel breast cancer susceptibility locus at 4q21 / Yosr Hamdi, Penny Soucy, Véronique Adoue, Kyriaki Michailidou, Sander Canisius, Audrey Lemaçon, Arna… , 2016. - 24 S.
In: OncoTarget, ISSN 1949-2553. 7(2016), 49, Seite 80140-80163
DOI: 10.18632/oncotarget.12818
Hennigs, André: Prognosis of breast cancer molecular subtypes in routine clinical care : a large prospective cohort study / André Hennigs, Fabian Riedel, Adam Gondos, Peter Sinn, Peter Schirmacher, Frederik Marmé, Dirk Jäger… , 15 September 2016
In: BMC cancer, ISSN 1471-2407. 16(2016) Artikel-Nummer 734, 9 Seiten
DOI: 10.1186/s12885-016-2766-3
Ghoussaini, Maya: Evidence that the 5p12 variant rs10941679 confers susceptibility to estrogen receptor positive breast cancer through FGF10 and MRPS30 regulation / Maya Ghoussaini, Juliet D. French, Kyriaki Michailidou, Silje Nord, Jonathan Beesley, Sander Canis… , October 6, 2016. - 9 S.
In: The American journal of human genetics, ISSN 1537-6605. 99(2016), 4, Seite 903-911
DOI: 10.1016/j.ajhg.2016.07.017
Hennigs, André: Prognosis of breast cancer molecular subtypes in routine clinical care : a large prospective cohort study / André Hennigs, Fabian Riedel, Adam Gondos, Peter Sinn, Peter Schirmacher, Frederik Marmé, Dirk Jäger… . -
London; Berlin; Heidelberg: BioMed Central; Springer, 2016. - 1 Online-Ressource
DOI: 10.1186/s12885-016-2766-3
Southey, Melissa C.: PALB2, CHEK2 and ATM rare variants and cancer risk : data from COGS / Melissa C. Southey, David E. Goldgar, Robert Winqvist, Katri Pylkäs, Fergus Couch, Marc Tischkowitz,… , September 5, 2016. - 12 S.
In: Journal of medical genetics, ISSN 1468-6244. 53(2016), Seite 800-811
DOI: 10.1136/jmedgenet-2016-103839
Lawrenson, Kate: Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus / Kate Lawrenson, Siddhartha Kar, Karen McCue, Karoline Kuchenbaeker, Kyriaki Michailidou, Jonathan Ty… , September 07, 2016. - 22 S.
In: Nature Communications, ISSN 2041-1723. 7(2016) Artikel-Nr. 12675, 22 S.
DOI: 10.1038/ncomms12675
Hänse, Nicole: A phase I trial of the trifunctional anti Her2 × anti CD3 antibody ertumaxomab in patients with advanced solid tumors / N. Haense, A. Atmaca, C. Pauligk, K. Steinmetz, F. Marmé, G.M. Haag, M. Rieger, O.G. Ottmann, P. Ruf… . -
London; Berlin; Heidelberg: BioMed Central; Springer, 2016. - 1 Online-Ressource (10 Seiten)
DOI: 10.1186/s12885-016-2449-0
Horne, Hisani N.: Fine-mapping of the 1p11.2 breast cancer susceptibility locus / Hisani N. Horne, Charles C. Chung, Han Zhang, Kai Yu, Ludmila Prokunina-Olsson, Kyriaki Michailidou,… , August 24, 2016. - 15 S.
In: PLOS ONE, ISSN 1932-6203. 11(2016,8), Artikel-Nummer e0160316, 15 Seiten
DOI: 10.1371/journal.pone.0160316
Guo, Yan: Genetically predicted body mass index and breast cancer risk : Mendelian randomization analyses of data from 145,000 women of European descent / Yan Guo, Shaneda Warren Andersen, Xiao-Ou Shu, Kyriaki Michailidou, Manjeet K. Bolla, Qin Wang, Mont… , August 23, 2016. - 18 S.
In: PLoS medicine, ISSN 1549-1676. 13(2016,8) Artikel-Nr. e1002105, 18 S.
DOI: 10.1371/journal.pmed.1002105
Zeng, Chenjie: Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus / Chenjie Zeng, Xingyi Guo, Jirong Long, Karoline B. Kuchenbaecker, Arnaud Droit, Kyriaki Michailidou,… , June 21, 2016. - 21 S.
In: Breast cancer research, ISSN 1465-542X. 18(2016) Artikel-Nummer 64, 21 Seiten
DOI: 10.1186/s13058-016-0718-0
Wyszynski, Asaf: An intergenic risk locus containing an enhancer deletion in 2q35 modulates breast cancer risk by deregulating IGFBP5 expression / Asaf Wyszynski, Chi-Chen Hong, Kristin Lam, Kyriaki Michailidou, Christian Lytle, Song Yao, Yali Zha… , July 11, 2016. - 52 S.
In: Human molecular genetics, ISSN 1460-2083. 25(2016), 17, Seite 3863-3876
DOI: 10.1093/hmg/ddw223
Shi, Jiajun: Fine-scale mapping of 8q24 locus identifies multiple independent risk variants for breast cancer / Jiajun Shi, Yanfeng Zhang, Wei Zheng, Kyriaki Michailidou, Maya Ghoussaini, Manjeet K. Bolla, Qin Wa… , 2016. - 15 S.
In: International journal of cancer, ISSN 1097-0215. 139(2016), 6, Seite 1303-1317
DOI: 10.1002/ijc.30150
Hollestelle, Antoinette: No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer / Ovarian Cancer Association Consortium, Breast Cancer Association Consortium, and Consortium of Modif… , May 2, 2015. - 16 S.
In: Gynecologic oncology, ISSN 1095-6859. 141(2016), 2, Seite 386-401
DOI: 10.1016/j.ygyno.2015.04.034
Couch, Fergus J.: Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer / Fergus J. Couch, Karoline B. Kuchenbaecker, Kyriaki Michailidou, Gustavo A. Mendoza-Fandino, Silje N… , April 27, 2016. - 13 S.
In: Nature Communications, ISSN 2041-1723. 7(2016) Artikel-Nr. 11375, 13 S.
DOI: 10.1038/ncomms11375
Zhao, Zhiguo: Association of genetic susceptibility variants for type 2 diabetes with breast cancer risk in women of European ancestry / Zhiguo Zhao, Wanqing Wen, Kyriaki Michailidou, Manjeet K. Bolla, Qin Wang, Ben Zhang, Jirong Long, X… , 2016. - 15 S.
In: Cancer causes & control, ISSN 1573-7225. 27(2016), 5, Seite 679-693
DOI: 10.1007/s10552-016-0741-6
Dunning, Alison M.: Breast cancer risk variants at 6q25 display different phenotype associations and regulate ESR1, RMND1 and CCDC170 / Alison M. Dunning, Kyriaki Michailidou, Karoline B. Kuchenbaecker, Deborah Thompson, Juliet D. Frenc… , 2016. - 13 S.
In: Nature genetics, ISSN 1546-1718. 48(2016), 4, Seite 374-386
DOI: 10.1038/ng.3521
Petridis, Christos: Genetic predisposition to ductal carcinoma in situ of the breast / Christos Petridis, Mark N. Brook, Vandna Shah, Kelly Kohut, Patricia Gorman, Michele Caneppele, Dina… , 2016. - 15 S.
In: Breast cancer research, ISSN 1465-542X. 18(2016) Artikel-Nummer 22, 15 Seiten
DOI: 10.1186/s13058-016-0675-7
Meeks, Huong D.: BRCA2 polymorphic stop codon K3326X and the risk of breast, prostate, and ovarian cancers / Huong D. Meeks, Honglin Song, Kyriaki Michailidou, Manjeet K. Bolla, Joe Dennis, Qin Wang, Daniel Ba… , 2016. - 10 S.
In: Journal of the National Cancer Institute, ISSN 1460-2105. 108(2016,2) Artikel-Nummer djv315, 10 Seiten
DOI: 10.1093/jnci/djv315
Petridis, Christos: Genetic predisposition to ductal carcinoma in situ of the breast / Christos Petridis, Mark N. Brook, Vandna Shah, Kelly Kohut, Patricia Gorman, Michele Caneppele, Dina… . -
London: BioMed Central, 2016. - 1 Online-Ressource (15 Seiten)
Lei, Jieping: Genetic variation in the immunosuppression pathway genes and breast cancer susceptibility : a pooled analysis of 42,510 cases and 40,577 controls from the Breast Cancer Association Consortium / Jieping Lei, Anja Rudolph, Kirsten B. Moysich, Sabine Behrens, Ellen L. Goode, Manjeet K. Bolla, Jo… , 2016. - 18 S.
In: Human genetics, ISSN 1432-1203. 135(2016), 1, Seite 137-154
DOI: 10.1007/s00439-015-1616-8
Marmé, Frederik: Utility of the CPS + EG staging system in hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer treated with neoadjuvant chemotherapy / Frederik Marmé, Bianca Lederer, Jens-Uwe Blohmer, Serban Dan Costa, Carsten Denkert, Holger Eidtmann… , 2016. - 10 S.
In: European journal of cancer, ISSN 1879-0852. 53(2016), Seite 65-74
DOI: 10.1016/j.ejca.2015.09.022
Minckwitz, Gunter von: A randomized phase 2 study comparing EC or CMF versus nab-paclitaxel plus capecitabine as adjuvant chemotherapy for nonfrail elderly patients with moderate to high-risk early breast cancer (ICE II-GBG 52) / Gunter von Minckwitz, MD; Bettina Conrad, MD; Toralf Reimer, MD; Thomas Decker, MD; Holger Eidtmann,… , 2015. - 10 S. : graph. Darst.
In: Cancer, ISSN 0008-543X. 121(2015), 20, Seite 3639-3648
Minckwitz, Gunter von: A randomized phase 2 study comparing EC or CMF versus nab-paclitaxel plus capecitabine as adjuvant chemotherapy for nonfrail elderly patients with moderate to high-risk early breast cancer (ICE II-GBG 52) / Gunter von Minckwitz, MD; Bettina Conrad, MD; Toralf Reimer, MD; Thomas Decker, MD; Holger Eidtmann,… , June 25, 2015. - 10 S.
In: Cancer, ISSN 1097-0142. 121(2015), 20, Seite 3639-3648
DOI: 10.1002/cncr.29506
Rath, Michèlle Geneviève: Predictors of residual tumor in breast-conserving therapy / Michelle G. Rath, Lorenz Uhlmann, Joerg Heil, Christoph Domschke, Zdravka Roth, Hans-Peter Sinn, Fre… , 30 July 2015. - 8 S.
In: Annals of surgical oncology, ISSN 1534-4681. 22(2015), 3, Seite 451-458
DOI: 10.1245/s10434-015-4736-4
Mavaddat, Nasim: Prediction of breast cancer risk based on profiling with common genetic variants / Nasim Mavaddat, Jenny Chang-Claude, Anja Rudolph, Petra Seibold, Barbara Burwinkel, Frederik Marme, … , April 2, 2015
In: Journal of the National Cancer Institute, ISSN 1460-2105. 107(2015,5) Artikel-Nummer djv036, 15 Seiten
DOI: 10.1093/jnci/djv036
Marmé, Frederik: Targeted therapies in triple-negative breast cancer / Frederik Marmé, Andreas Schneeweiss, June 24, 2015. - 8 S.
In: Breast care, ISSN 1661-3805. 10(2015), 3, Seite 159-166
DOI: 10.1159/000433622
Huober, Jens: News from ASCO 2015 : what was relevant for breast cancer experts? / chair: Jens Huober; participants: Thomas Decker, Cornelia Liedtke, Frederik Marmé, Norbert Marschner… , August 24, 2015. - 4 S.
In: Breast care, ISSN 1661-3805. 10(2015), 4, Seite 285-288
DOI: 10.1159/000439298
Arpino, Grazia: Tailoring the dosing schedule of nab-paclitaxel in metastatic breast cancer according to patient and disease characteristics : recommendations from a panel of experts / G. Arpino, F. Marmé, J. Cortés, E. Ricevuto, R. Leonard, A. Llombart-Cussac, 2016. - 10 S.
In: Critical reviews in oncology, hematology, ISSN 1879-0461. 99(2016), Seite 81-90
DOI: 10.1016/j.critrevonc.2015.10.007
Peng, Cike: Plasma hyaluronic acid level as a prognostic and monitoring marker of metastatic breast cancer / Cike Peng, Markus Wallwiener, Anja Rudolph, Katarina Ćuk, Ursula Eilber, Muhabbet Celik, Caroline Mo… , 2016. - 11 S.
In: International journal of cancer, ISSN 1097-0215. 138(2016), 10, Seite 2499-2509
DOI: 10.1002/ijc.29975
Michel, Laura L.: T-DM1 as a new treatment option for patients with metastatic HER2-positive breast cancer in clinical practice / Laura L. Michel, Justo Lorenzo Bermejo, Adam Gondos, Frederik Marmé and Andreas Schneeweiss, September 2015. - 6 S.
In: Anticancer research, ISSN 1791-7530. 35(2015), 9, Seite 5085-5090
Würstlein, Rachel: News from the San Antonio Breast Cancer Symposium 2014 / Rachel Würstlein, Alessandra Gennari, Cornelia Liedtke, Frederik Marmé. - 4 S.
In: Breast care, ISSN 1661-3805. 10(2015), 1, S. 61-64
DOI: 10.1159/000381090
Zhang, Ben: Height and breast cancer risk : evidence from prospective studies and mendelian randomization / Ben Zhang, Xiao-Ou Shu, Ryan J. Delahanty, Chenjie Zeng, Kyriaki Michailidou, Manjeet K. Bolla, Qin … , 2015. - 17 S.
In: Journal of the National Cancer Institute, ISSN 1460-2105. 107(2015,1) Artikel-Nummer djv219, 17 Seiten
DOI: 10.1093/jnci/djv219
Pirie, Ailith: Common germline polymorphisms associated with breast cancer-specific survival / Ailith Pirie, Qi Guo, Peter Kraft, Sander Canisius, Diana M. Eccles, Nazneen Rahman, Heli Nevanlinna… . -
London: BioMed Central, 2015. - 1 Online-Ressource (12 Seiten)
Jamshidi, Maral: SNP-SNP interaction analysis of NF-kappaB signaling pathway on breast cancer survival / Maral Jamshidi, Rainer Fagerholm, Sofia Khan, Kristiina Aittomäki, Kamila Czene, Hatef Darabi, Jingm… , 2015. - 16 S.
In: OncoTarget, ISSN 1949-2553. 6(2015), 35, Seite 37979-37994
DOI: 10.18632/oncotarget.4991
Guo, Xingyi: Fine-scale mapping of the 4q24 locus identifies two independent loci associated with breast cancer risk / Xingyi Guo, Jirong Long, Chenjie Zeng, Kyriaki Michailidou, Maya Ghoussaini, Manjeet K. Bolla, Qin W… , 2015. - 12 S.
In: Cancer epidemiology, biomarkers & prevention, ISSN 1538-7755. 24(2015), 11, Seite 1680-1691
DOI: 10.1158/1055-9965.EPI-15-0363
Guo, Qi: Identification of novel genetic markers of breast cancer survival / Qi Guo, Marjanka K. Schmidt, Peter Kraft, Sander Canisius, Constance Chen, Sofia Khan, Jonathan Tyre… , 2015. - 9 S.
In: Journal of the National Cancer Institute, ISSN 1460-2105. 107(2015,5) Artikel-Nummer djv081, 9 Seiten
DOI: 10.1093/jnci/djv081
Darabi, Hatef: Polymorphisms in a putative enhancer at the 10q21.2 breast cancer risk locus regulate NRBF2 Expressi / Hatef Darabi, Karen McCue, Jonathan Beesley, Kyriaki Michailidou, Silje Nord, Siddhartha Kar, Keith … , 2015. - 13 S.
In: The American journal of human genetics, ISSN 1537-6605. 97(2015), 1, Seite 22-34
DOI: 10.1016/j.ajhg.2015.05.002
Pirie, Ailith: Common germline polymorphisms associated with breast cancer specific survival / Ailith Pirie, Qi Guo, Peter Kraft, Sander Canisius, Diana M. Eccles, Nazneen Rahman, Heli Nevanlinna… , 2015. - 11 S.
In: Breast cancer research, ISSN 1465-542X. 17(2015), Artikel-ID 58, Seite 1-11
DOI: 10.1186/s13058-015-0570-7
Orr, Nick: Fine-mapping identifies two additional breast cancer susceptibility loci at 9q31.2 / Nick Orr, Frank Dudbridge, Nicola Dryden, Sarah Maguire, Daniela Novo, Eleni Perrakis, Nichola Johns… , 2015. - 19 S.
In: Human molecular genetics, ISSN 1460-2083. 24(2015), 10, Seite 2966-2984
DOI: 10.1093/hmg/ddv035
Yang, Rongxi: DNA methylation array analyses identified breast cancer-associated HYAL2 methylation in peripheral blood / Rongxi Yang, Katrin Pfütze, Manuela Zucknick, Christian Sutter, Barbara Wappenschmidt, Frederik Marm… , 2015. - 11 S.
In: International journal of cancer, ISSN 1097-0215. 136(2015), 8, Seite 1845-1855
DOI: 10.1002/ijc.29205
Painter, Jodie N.: Fine-mapping of the HNF1B multicancer locus identifies candidate variants that mediate endometrial cancer risk / Jodie N. Painter ... Barbara Burwinkel, Frederik Marmé, Hermann Brenner ..., 2015. - 15 S.
In: Human molecular genetics, ISSN 1460-2083. 24(2015), 5, Seite 1478-1492
DOI: 10.1093/hmg/ddu552
Kabisch, Maria: Inherited variants in the inner centromere protein (INCENP) gene of the chromosomal passenger complex contribute to the susceptibility of ER-negative breast cancer / Maria Kabisch, Justo Lorenzo Bermejo ... Barbara Burwinkel, Frederik Marmé ... Peter Bugert ... Herm… , 2015. - 16 S.
In: Carcinogenesis, ISSN 1460-2180. 36(2015), 2, Seite 256-271
DOI: 10.1093/carcin/bgu326
Carvajal-Carmona, Luis G.: Candidate locus analysis of the TERT-CLPTM1L cancer risk region on chromosome 5p15 identifies multiple independent variants associated with endometrial cancer risk / Luis G. Carvajal-Carmona, Tracy A. O’Mara, Jodie N. Painter, Felicity A. Lose, Joe Dennis, Kyriaki M… , 2015. - 15 S.
In: Human genetics <Berlin>, ISSN 0340-6717. 134(2015), 2, Seite 231-245
Carvajal-Carmona, Luis G.: Candidate locus analysis of the TERT-CLPTM1L cancer risk region on chromosome 5p15 identifies multiple independent variants associated with endometrial cancer risk / Luis G. Carvajal-Carmona, Tracy A. O’Mara, Jodie N. Painter, Felicity A. Lose, Joe Dennis, Kyriaki M… , 2015. - 15 S.
In: Human genetics, ISSN 1432-1203. 134(2015), 2, Seite 231-245
DOI: 10.1007/s00439-014-1515-4
Agarwal, Deepak K.: FGF receptor genes and breast cancer susceptibility : results from the Breast Cancer Association Consortium / D. Agarwal, S. Pineda, K. Michailidou, J. Herranz, G. Pita, L.T. Moreno, M.R. Alonso, J. Dennis, Q. … , 18 February 2014. - 13 S.
In: British journal of cancer, ISSN 1532-1827. 110(2014), 4, Seite 1088-1100
DOI: 10.1038/bjc.2013.769
Schneeweiss, Andreas: Efficacy of nab-paclitaxel does not seem to be associated with SPARC expression in metastatic breast cancer / Andreas Schneeweiss, Julia Seitz, Katharina Smetanay, Florian Schuetz, Dirk Jaeger, Andreas Bachinge… , August 4, 2014. - 7 S.
In: Anticancer research, ISSN 1791-7530. 34(2014), 11, Seite 6609-6615
Milne, Roger L.: Common non-synonymous SNPs associated with breast cancer susceptibility : findings from the Breast Cancer Association Consortium / Roger L. Milne, Barbara Burwinkel, Kyriaki Michailidou, Jose-Ignacio Arias-Perez, M. Pilar Zamora, P… , 18 June 2014. - 16 S.
In: Human molecular genetics, ISSN 1460-2083. 23(2014), 22, Seite 6096-6111
DOI: 10.1093/hmg/ddu311
Schouten, Philip: Breast cancers with a BRCA1-like DNA copy number profile recur less often than expected after high-dose alkylating chemotherapy / Philip C. Schouten, Frederik Marmé, Sebastian Aulmann, Hans-Peter Sinn, Hendrik F. van Essen, Bauke … , 2015. - 8 S.
In: Clinical cancer research, ISSN 1557-3265. 21(2015), 4, Seite 763-770
DOI: 10.1158/1078-0432.CCR-14-1894
Lin, Wei-Yu: Identification and characterization of novel associations in the CASP8/ALS2CR12 region on chromosome 2 with breast cancer risk / Wei-Yu Lin, Nicola J. Camp, Maya Ghoussaini, Jonathan Beesley, Kyriaki Michailidou, John L. Hopper, … , 2015. - 14 S.
In: Human molecular genetics, ISSN 1460-2083. 24(2015), 1, Seite 285-298
DOI: 10.1093/hmg/ddu431
Glubb, Dylan M.: Fine-scale mapping of the 5q11.2 breast cancer locus reveals at least three independent risk variants regulating MAP3K1 / Dylan M. Glubb, Mel J. Maranian, Kyriaki Michailidou, Karen A. Pooley, Kerstin B. Meyer, Siddhartha … , 2015. - 16 S.
In: The American journal of human genetics, ISSN 1537-6605. 96(2015), 1, Seite 5-20
DOI: 10.1016/j.ajhg.2014.11.009
Johnson, Nichola: Genetic variation at CYP3A is associated with age at menarche and breast cancer risk : a case-control study / Nichola Johnson, Frank Dudbridge, Nick Orr, Lorna Gibson, Michael E. Jones, Minouk J. Schoemaker, El… . -
London: BioMed Central, 2014. - 1 Online-Ressource (13 Seiten)
DOI: 10.1186/bcr3662
Spurdle, Amanda B.: Refined histopathological predictors of BRCA1 and BRCA2 mutation status: a large-scale analysis of breast cancer characteristics from the BCAC, CIMBA, and ENIGMA consortia / Amanda B. Spurdle, Fergus J. Couch, Michael T. Parsons, Lesley McGuffog, Daniel Barrowdale, Manjeet … . -
London: BioMed Central, 2016. - 1 Online-Ressource (16 Seiten)
DOI: 10.1186/s13058-014-0474-y
Wallwiener, Markus: Serial enumeration of circulating tumor cells predicts treatment response and prognosis in metastatic breast cancer : a prospective study in 393 patients / Markus Wallwiener, Sabine Riethdorf, Andreas Daniel Hartkopf, Caroline Modugno, Juliane Nees, Dharan… , 11 July 2014. - 12 S.
In: BMC cancer, ISSN 1471-2407. 14(2014) Artikel-Nummer 512, 12 Seiten
DOI: 10.1186/1471-2407-14-512
Kahn, Sofia: MicroRNA related polymorphisms and breast cancer risk / Sofia Khan, Dario Greco, Kyriaki Michailidou, Roger L. Milne, Taru A. Muranen, Tuomas Heikkinen, Kir… , 2014. - 12 S.
In: PLOS ONE, ISSN 1932-6203. 9(2014,11) Artikel-Nr. e109973, 12 S.
DOI: 10.1371/journal.pone.0109973
Pietzner, Klaus: Re-challenge with catumaxomab in patients with malignant ascites : results from the SECIMAS study / Klaus Pietzner, Ignace Vergote, Armando Santoro, Radoslav Chekerov, Frederik Marmé, Per Rosenberg, H…
In: Medical oncology, ISSN 1559-131X. 31(2014) Artikel-Nr. 308, 8 S.
DOI: 10.1007/s12032-014-0308-x
Purrington, Kristen S.: Genetic variation in mitotic regulatory pathway genes is associated with breast tumor grade / Kristen S. Purrington, Seth Slettedahl, Manjeet K. Bolla, Kyriaki Michailidou, Kamila Czene, Heli Ne… , 2014. - 13 S.
In: Human molecular genetics, ISSN 1460-2083. 23(2014), 22, Seite 6034-6046
DOI: 10.1093/hmg/ddu300
Johnson, Nichola: Genetic variation at CYP3A is associated with age at menarche and breast cancer risk : a case-control study / Nichola Johnson ... Barbara Burwinkel, Frederik Marmé, Andreas Schneeweiss, Christof Sohn ... Jörg H… , 2014. - 13 S.
In: Breast cancer research, ISSN 1465-542X. 16(2014), 3, Artikel-ID R51, Seite 1-13
DOI: 10.1186/bcr3662
Milne, Roger L.: Common non-synonymous SNPs associated with breast cancer susceptibility : findings from the Breast Cancer Association Consortium / Roger L. Milne, Barbara Burwinkel, Kyriaki Michailidou, Jose-Ignacio Arias-Perez, M. Pilar Zamora, P… , 2014. - 16 S.
In: Human molecular genetics, ISSN 0964-6906. 23(2014), 22, Seite 6096-6111
Purrington, Kristen S.: Genetic variation in mitotic regulatory pathway genes is associated with breast tumor grade / Kristen S. Purrington, Seth Slettedahl, Manjeet K. Bolla, Kyriaki Michailidou, Kamila Czene, Heli Ne… , 2014. - 13 S.
In: Human molecular genetics, ISSN 0964-6906. 23(2014), 22, Seite 6034-6046
Rom, Joachim: Efficacy and toxicity profile of pegylated liposomal doxorubicin (Caelyx) in patients with advanced breast cancer / Rom, Joachim; Bechstein, Sarah; Domschke, Christoph; Golatta, Michael; Mayer, Christine; Heil, Joerg… , 2014. - 6 S.
In: Anti-cancer drugs, ISSN 1473-5741. 25(2014), 2, Seite 219-224
DOI: 10.1097/CAD.0000000000000037
Marmé, Frederik: Identifizierung und Validierung neuer prognostischer und prädiktiver Faktoren bei gynäkologischen Tumoren : Bedeutung genetischer Polymorphismen / vorgelegt von Frederik Marmé, 2013 [ersch.] 2014. - Getr. Zählung : Ill., graph. Darst.
Türbachova, Ivana: The cellular ratio of immune tolerance (immunoCRIT) is a definite marker for aggressiveness of solid tumors and may explain tumor dissemination patterns / Ivana Türbachova, Tim Schwachula, Ines Vasconcelos, Alexander Mustea, Tina Baldinger, Katherine A Jo… , 26 Sep 2013. - 10 S.
In: Epigenetics, ISSN 1559-2308. 8(2013), 11, Seite 1226-1235
DOI: 10.4161/epi.26334
Sinn, Peter: Multigene assays for classification, prognosis, and prediction in breast cancer : a critical review on the background and clinical utility / P. Sinn, S. Aulmann, R. Wirtz, S. Schott, F. Marmé, Z. Varga, A. Lebeau, H. Kreipe, A. Schneeweiss, 2013. - 9 S.
In: Geburtshilfe und Frauenheilkunde, ISSN 1438-8804. 73(2013), 9, Seite 932-940
DOI: 10.1055/s-0033-1350831
Rom, Joachim: Association of HER2 overexpression and prognosis in small (T1N0) primary breast cancers / Joachim Rom, Claudia Schumacher, Oleg Gluz, Josef Höfler, Sebastian Eidt, Christoph Domschke, Freder… , June 22, 2013. - 7 S.
In: Breast care, ISSN 1661-3805. 8(2013), 3 vom: Juni, Seite 208-214
DOI: 10.1159/000352094
Marmé, Frederik: Neoadjuvant epirubicin, gemcitabine and docetaxel for primary breast cancer : long-term survival data and major prognostic factors based on two consecutive neoadjuvant phase I/II trials / Frederik Marmé, Julia Aigner, Justo Lorenzo Bermejo, Peter Sinn, Christof Sohn, Dirk Jäger and Andre… , 7 February 2013. - 10 S.
In: International journal of cancer, ISSN 1097-0215. 133(2013), 4, Seite 1006-1015
DOI: 10.1002/ijc.28094
Cuk, Katarina: Plasma microRNA panel for minimally invasive detection of breast cancer / Katarina Cuk, Manuela Zucknick, Dharanija Madhavan, Sarah Schott, Michael Golatta, Jörg Heil, Freder… , October 23, 2013. - 10 S.
In: PLOS ONE, ISSN 1932-6203. 8(2013), 10, Artikel-ID e76729, Seite 1-10
DOI: 10.1371/journal.pone.0076729
Michailidou, Kyriaki: Large-scale genotyping identifies 41 new loci associated with breast cancer risk / Kyriaki Michailidou, Jenny Chang-Claude, Rebecca Hein, Anja Rudolph, Frederik Marme, Andreas Schnee… , 27 March 2013. - 11 S.
In: Nature genetics, ISSN 1546-1718. 45(2013), 4, Seite 353-361
DOI: 10.1038/ng.2563
Meyer, Kerstin B.: Fine-scale mapping of the FGFR2 breast cancer risk locus : putative functional variants differentially bind FOXA1 and E2F1 / Kerstin B. Meyer, Federick Marme, Andreas Schneeweiss, Christof Sohn, Barbara Burwinkel, Hermann Bre… , 27 November 2013. - 15 S.
In: The American journal of human genetics, ISSN 1537-6605. 93(2013), 6, Seite 1046-1060
DOI: 10.1016/j.ajhg.2013.10.026
French, Juliet D.: Functional variants at the 11q13 risk locus for breast cancer regulate cyclin D1 expression through long-range enhancers / Juliet D. French, Maya Ghoussaini, Stacey L. Edwards, Kerstin B. Meyer, Kyriaki Michailidou, Shahana… , 4 April 2013. - 15 S.
In: The American journal of human genetics, ISSN 1537-6605. 92(2013), 4, Seite 489-503
DOI: 10.1016/j.ajhg.2013.01.002
Aigner, Julia: Omission of axillary dissection according to ACOSOG Z0011 : impact on adjuvant treatment recommendations / Julia Aigner, Katharina Smetanay, Holger Hof, Hans-Peter Sinn, Christof Sohn, Andreas Schneeweiss, a… , 7 February 2013. - 7 S.
In: Annals of surgical oncology, ISSN 1534-4681. 20(2013), Seite 1538-1544
DOI: 10.1245/s10434-012-2798-0
Aigner, Julia: Nab-paclitaxel monotherapy as a treatment of patients with metastatic breast cancer in routine clinical practice / Julia Aigner, Frederik Marmé, Katharina Smetanay, Florian Schuetz, Dirk Jaeger and Andreas Schneewei… , August 2013. - 7 S.
In: Anticancer research, ISSN 1791-7530. 33(2013), 8 vom: Aug., Seite 3407-3413
Garcia-Closas, Montserrat: Genome-wide association studies identify four ER negative-specific breast cancer risk loci / Montserrat Garcia-Closas, Jenny Chang-Claude, Barbara Burwinkel, Hermann Brenner, Ute Hamann, Federi… , 27 March 2013. - 7 S.
In: Nature genetics, ISSN 1546-1718. 45(2013), 4, Seite 392-398
DOI: 10.1038/ng.2561
Bojesen, Stig Egil: Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer / Stig E. Bojesen, Jenny Chang-Claude, Barbara Burwinkel, Frederik Marme, Rebecca Hein, Hermann Brenn… , 27 March 2013. - 14 S.
In: Nature genetics, ISSN 1546-1718. 45(2013), 4, Seite 371-384
DOI: 10.1038/ng.2566
Baccelli, Irène: Identification of a population of blood circulating tumor cells from breast cancer patients that initiates metastasis in a xenograft assay / Irène Baccelli, Andreas Schneeweiss, Sabine Riethdorf, Albrecht Stenzinger, Anja Schillert, Vanessa … , 21 April 2013. - 6 S.
In: Nature biotechnology, ISSN 1546-1696. 31(2013), 6, Seite 539-544
DOI: 10.1038/nbt.2576
Milne, Roger L.: A large-scale assessment of two-way SNP interactions in breast cancer susceptibility using 46 450 cases and 42 461 controls from the breast cancer association consortium / Roger L. Milne, Jesús Herranz, Kyriaki Michailidou, Joe Dennis, Jonathan P. Tyrer, M. Pilar Zamora, … , 2014. - 13 S.
In: Human molecular genetics, ISSN 1460-2083. 23(2014), 7, Seite 1934-1946
DOI: 10.1093/hmg/ddt581
Bretz, Niko: Body fluid exosomes promote secretion of inflammatory cytokines in monocytic cells via toll-like receptor signaling / Bretz, Niko P. ... Rimbach, Katharina ... Rupp, Christian; Marme, Frederik ... Umansky, Viktor; Eige… , 2013. - 12 S.
In: The journal of biological chemistry, ISSN 1083-351X. 288(2013), 51, Seite 36691-36702
DOI: 10.1074/jbc.M113.512806
Garcia-Closas, Montserrat: Genome-wide association studies identify four ER negative-specific breast cancer risk loci / Montserrat Garcia-Closas, Jenny Chang-Claude, Barbara Burwinkel, Hermann Brenner, Ute Hamann, Federi… , 2013. - 7 S.
In: Nature genetics, ISSN 1061-4036. 45(2013), 4, Seite 392-398
Buck, Katharina: CD24 polymorphisms in breast cancer: impact on prognosis and risk / K. Buck ... C. Sohn; A. Schneeweiss ... D. Jäger ... F. Marmé, 2013. - 11 S.
In: Breast cancer research and treatment, ISSN 0167-6806. 137(2013), 3, Seite 927-937
Warren, Helen: 9q31.2-rs865686 as a susceptibility locus for estrogen receptor-positive breast cancer : evidence from the Breast Cancer Association Consortium / Helen Warren, Frank Dudbridge, Olivia Fletcher, Nick Orr, Nichola Johnson, John L Hopper, Carmel Api… , 2012. - 9 S.
In: Cancer epidemiology, biomarkers & prevention, ISSN 1055-9965. 21(2012), 10 vom: Okt., Seite 1783-1791
DOI: 10.1158/1055-9965.EPI-12-0526
Stevens, Kristen N.: 19p13.1 is a triple-negative-specific breast cancer susceptibility locus / Kristen N Stevens, Zachary Fredericksen, Celine M Vachon, Xianshu Wang, Sara Margolin, Annika Lindbl… , 2012. - 9 S.
In: Cancer research, ISSN 0008-5472. 72(2012), 7 vom: 1. Apr., Seite 1795-1803
DOI: 10.1158/0008-5472.CAN-11-3364
Lambrechts, Diether: 11q13 is a susceptibility locus for hormone receptor positive breast cancer / Diether Lambrechts, Therese Truong, Christina Justenhoven, Manjeet K. Humphreys, Jean Wang, John L. … , 2012. - 10 S.
In: Human mutation, ISSN 1059-7794. 33(2012), 7 vom: Juli, Seite 1123-1132
Weischer, Maren: CHEK2*1100delC heterozygosity in women with breast cancer associated with early death, breast cancer-specific death, and increased risk of a second breast cancer / Maren Weischer, Børge G. Nordestgaard, Paul Pharoah, Manjeet K. Bolla, Heli Nevanlinna, Laura J. van… , October 29, 2012. - 9 S.
In: Journal of clinical oncology, ISSN 1527-7755. 30(2012), 35, Seite 4308-4316
DOI: 10.1200/JCO.2012.42.7336
Warren, Helen: 9q31.2-rs865686 as a susceptibility locus for estrogen receptor-positive breast cancer : evidence from the Breast Cancer Association Consortium / Helen Warren, Frank Dudbridge, Olivia Fletcher, Nick Orr, Nichola Johnson, John L. Hopper, Carmel Ap… . - 13 S.
In: Cancer epidemiology, biomarkers & prevention, ISSN 1538-7755. 21(2012), 10, S. 1783-1791
DOI: 10.1158/1055-9965.EPI-12-0526
Fasching, Peter Andreas: The role of genetic breast cancer susceptibility variants as prognostic factors / Peter A. Fasching, Paul D.P. Pharoah, Angela Cox, Heli Nevanlinna, Stig E. Bojesen, Thomas Karn, Ann… , 01 September 2012. - 14 S.
In: Human molecular genetics, ISSN 1460-2083. 21(2012), 17, Seite 3926-3939
DOI: 10.1093/hmg/dds159
Lambrechts, Diether: 11q13 is a susceptibility locus for hormone receptor positive breast cancer / Diether Lambrechts, Therese Truong, Christina Justenhoven, Manjeet K. Humphreys, Jean Wang, John L. … , July 2012. - 10 S.
In: Human mutation, ISSN 1098-1004. 33(2012), 7, Seite 1123-1132
DOI: 10.1002/humu.22089
Marmé, Frederik: Personalized therapy in breast cancer / Frederik Marmé, Andreas Schneeweiss, 2012. - 6 S.
In: Onkologie, ISSN 1423-0240. 35(2012), Suppl. 1, Seite 28-33
DOI: 10.1159/000334973
Marmé, Frederik: Fibroblast growth factor receptor 4 gene (FGFR4) 388Arg allele predicts prolonged survival and platinum sensitivity in advanced ovarian cancer / Frederik Marmé, Thomas Hielscher, Sarah Hug, Sandra Bondong, Robert Zeillinger, Dan Cacsire Castillo… , 2012. - 6 S.
In: International journal of cancer, ISSN 1097-0215. 131(2012), 4, Seite E586-E591
DOI: 10.1002/ijc.27329
Marmé, Frederik: Adjuvante Aromatasehemmertherapie beim Mammakarzinom / F. Marmé. - 3 S.
In: Der Onkologe, ISSN 1433-0415. 18(2012), 9, S. 808-810
DOI: 10.1007/s00761-012-2303-1
Stevens, Kristen N.: 19p13.1 is a triple-negative-specific breast cancer susceptibility locus / Kristen N. Stevens, Zachary Fredericksen, Celine M. Vachon, Xianshu Wang, Sara Margolin, Annika Lind… , February 13, 2012. - 9 S.
In: Cancer research, ISSN 1538-7445. 72(2012), 7, Seite 1795-1803
DOI: 10.1158/0008-5472.CAN-11-3364
Wallwiener, Markus: The prognostic impact of circulating tumor cells in subtypes of metastatic breast cancer / Markus Wallwiener, Andreas Daniel Hartkopf, Irène Baccelli, Sabine Riethdorf, Sarah Schott, Klaus Pa… . - 8 S.
In: Breast cancer research and treatment, ISSN 1573-7217. 137(2013), 2, S. 503-510
DOI: 10.1007/s10549-012-2382-0
Heil, Jörg: Outcome analysis of patients with primary breast cancer initially treated at a certified academic breast unit / J. Heil, A. Gondos, G. Rauch, F. Marmé, J. Rom, M. Golatta, H. Junkermann, P. Sinn, S. Aulmann, J. D… , 4 February 2012. - 6 S.
In: The breast, ISSN 1532-3080. 21(2012), 3, Seite 303-308
DOI: 10.1016/j.breast.2012.01.009
Rath, Michèlle Geneviève: Predictors of resectability in breast-conserving therapy / Michelle G. Rath, Joerg Heil, Christoph Domschke, Zdravka Topic, Sven Schneider, Hans-Peter Sinn, Fr… , 17 June 2012. - 9 S.
In: Archives of gynecology and obstetrics, ISSN 1432-0711. 286(2012), 4, Seite 1023-1031
DOI: 10.1007/s00404-012-2401-8
Marmé, Frederik: Personalized therapy in breast cancer / Frederik Marmé ; Andreas Schneeweiß. -
Basel: S. Karger, 2012. - Online-Ressource (7 S.)
Hein, Rebecca: Comparison of 6q25 breast cancer hits from Asian and European genome wide association studies in the Breast Cancer Association Consortium (BCAC) / R. Hein ... F. Marmé, A. Schneeweiss, C. Sohn, B. Burwinkel, ... H. Brenner ... S. Schott, C.R. Bart… , 2012. - 14 S.
In: PLOS ONE, ISSN 1932-6203. 7(2012,8) Artikel-Nr. e42380, 14 Seiten
Peterlongo, Paolo: The rs12975333 variant in the miR-125a and breast cancer risk in Germany, Italy, Australia and Spain / Paolo Peterlongo, Laura Caleca, Elisa Cattaneo, Fernando Ravagnani, Tiziana Bianchi, Laura Galastri,… , 19 September 2011. - 2 S.
In: Journal of medical genetics, ISSN 1468-6244. 48(2011), 10, Seite 703-704
DOI: 10.1136/jmedgenet-2011-100103
Schneeweiss, Andreas: A randomized phase II trial of doxorubicin plus pemetrexed followed by docetaxel versus doxorubicin plus cyclophosphamide followed by docetaxel as neoadjuvant treatment of early breast cancer / A. Schneeweiss, F. Marmé, A. Ruiz, A. G. Manikhas, A. Bottini, M. Wolf, H. -P. Sinn, K. Mansouri, L.… , [March 2011]. - 9 S.
In: Annals of oncology, ISSN 1569-8041. 22(2011), 3, Seite 609-617
DOI: 10.1093/annonc/mdq400
Rupp, Anne-Kathleen: Loss of EpCAM expression in breast cancer derived serum exosomes : role of proteolytic cleavage / Anne-Kathleen Rupp, Christian Rupp, Sascha Keller, Jan C. Brase, Robert Ehehalt, Mina Fogel, Gerhard… , 20 May 2011. - 10 S.
In: Gynecologic oncology, ISSN 1095-6859. 122(2011), 2, Seite 437-446
DOI: 10.1016/j.ygyno.2011.04.035
Milne, Roger L.: Confirmation of 5p12 as a susceptibility locus for progesterone-receptor-positive, lower grade breast cancer / Roger L. Milne, Ellen L. Goode, Montserrat García-Closas, Fergus J. Couch, Gianluca Severi, Rebecca … , October 05 2011. - 10 S.
In: Cancer epidemiology, biomarkers & prevention, ISSN 1538-7755. 20(2011), 10, Seite 2222-2231
DOI: 10.1158/1055-9965.EPI-11-0569
Broeks, Annegien: Low penetrance breast cancer susceptibility loci are associated with specific breast tumor subtypes : findings from the Breast Cancer Association Consortium / Annegien Broeks, Marjanka K. Schmidt, Mark E. Sherman, Fergus J. Couch, John L. Hopper, Gillian S. D… , 19 May 2011. - 15 S.
In: Human molecular genetics, ISSN 1460-2083. 20(2011), 16, Seite 3289-3303
DOI: 10.1093/hmg/ddr228
Domschke, Christoph: Determination of paraneoplastic autoimmune responses by tumor cell biology and intratumoral IFN-alpha/IL-12 in breast cancer patients / Christoph Domschke, Florian Schuetz, Yingzi Ge, Joachim Rom, Markus Zorn, Hans-Peter Sinn, Frederik … , 2011. - 11 S.
In: Cancer immunology immunotherapy, ISSN 1432-0851. 60(2011), 3, Seite 401-411
DOI: 10.1007/s00262-010-0956-4
Figueroa, Jonine: Associations of common variants at 1p11.2 and 14q24.1 (RAD51L1) with breast cancer risk and heterogeneity by tumor subtype : findings from the Breast Cancer Association Consortium / Jonine D. Figueroa, Montserrat Garcia-Closas, Manjeet Humphreys, Radka Platte, John L. Hopper, Melis… , 18 August 2011. - 14 S.
In: Human molecular genetics, ISSN 1460-2083. 20(2011), 23, Seite 4693-4706
DOI: 10.1093/hmg/ddr368
Marmé, Frederik: CD24 Ala57Val polymorphism predicts pathologic complete response to sequential anthracycline- and taxane-based neoadjuvant chemotherapy for primary breast cancer / Frederik Marmé, Wiebke Werft, Anne Walter, Sascha Keller, Xiaoli Wang, Axel Benner, Barbara Burwinke… , 2012. - 13 S.
In: Breast cancer research and treatment, ISSN 1573-7217. 132(2012), 3, Seite 819-831
DOI: 10.1007/s10549-011-1759-9
Ott, Marion Gabriele: Humoral response to catumaxomab correlates with clinical outcome : results of the pivotal phase II/III study in patients with malignant ascites / Marion G. Ott, Frederik Marmé, Gerhard Moldenhauer, Horst Lindhofer, Michael Hennig, Rolf Spannagl, … . - 9 S.
In: International journal of cancer, ISSN 1097-0215. 130(2012), 9, S. 2195-2203
DOI: 10.1002/ijc.26258
Schneeweiss, Andreas: A randomized phase II trial of doxorubicin plus pemetrexed followed by docetaxel versus doxorubicin plus cyclophosphamide followed by docetaxel as neoadjuvant treatment of early breast cancer / Schneeweiss, A.; Marmé, F. ... Sinn, H. P. ..., 2011. - 9 S.
In: Annals of oncology, ISSN 0923-7534. 22(2011), 3, Seite 609-17
Figueroa, Jonine: Associations of common variants at 1p11.2 and 14q24.1 (RAD51L1) with breast cancer risk and heterogeneity by tumor subtype: findings from the Breast Cancer Association Consortium / Jonine D. Figueroa, Montserrat Garcia-Closas, Manjeet Humphreys, Radka Platte, John L. Hopper, Melis… , 2011. - 14 S.
In: Human molecular genetics, ISSN 0964-6906. 20(2011), 23, Seite 4693-4706
Broeks, Annegien: Low penetrance breast cancer susceptibility loci are associated with specific breast tumor subtypes : findings from the Breast Cancer Association Consortium / A. Broeks; ... B. Burwinkel; F. Marme; A. Schneeweiss; H.P. Sinn; C. Sohn ... S. Tchatchou ... U. Ha… , 2011. - 15 S.
In: Human molecular genetics, ISSN 0964-6906. 20(2011), 16, Seite 3289-3303
Milne, Roger L.: Confirmation of 5p12 as a susceptibility locus for progesterone-receptor-positive, lower grade breast cancer / Roger L. Milne, ... Jenny Chang-Claude, ... Hermann Brenner, Heiko Müller, Volker Arndt, ... Joerg H… , 2011. - 10 S.
In: Cancer epidemiology, biomarkers & prevention, ISSN 1055-9965. 20(2011), 10, Seite 2222-2231
Marmé, Frederik: FGFR4 Arg388 genotype is associated with pathological complete response to neoadjuvant chemotherapy for primary breast cancer / F. Marmé, W. Werft, A. Benner, B. Burwinkel, P. Sinn, C. Sohn, P. Lichter, M. Hahn & A. Schneeweiss, 10 February 2010. - 7 S.
In: Annals of oncology, ISSN 1569-8041. 21(2010), 8, Seite 1636-1642
DOI: 10.1093/annonc/mdq017
Macher-Göppinger, Stephan: Invasive ductal breast cancer within a malignant phyllodes tumor : case report and assessment of clonality / Stephan Macher-Goeppinger, Frederik Marme, Benjamin Goeppert, Roland Penzel, Peter Schirmacher, Hans… , 2010. - 4 S.
In: Human pathology, ISSN 1532-8392. 41(2010), 2 vom: Feb., Seite 293-296
DOI: 10.1016/j.humpath.2009.08.006
Heil, Jörg: Aesthetic and functional results after breast conserving surgery as correlates of quality of life measured by a German version of the Breast Cancer Treatment Outcome Scale (BCTOS) / Joerg Heil, Simone Holl, Michael Golatta, Geraldine Rauch, Joachim Rom, Frederik Marmé, Gerhard Geba… , [December 2010]. - 5 S.
In: The breast, ISSN 1532-3080. 19(2010), 6 vom: Dez., Seite 470-474
DOI: 10.1016/j.breast.2010.05.004
Kristiansen, Glen: Molecular and clinical dissection of CD24 antibody specificity by a comprehensive comparative analysis / Glen Kristiansen, Eda Machado, Niko Bretz, Christian Rupp, Klaus-Jürgen Winzer, Anne-Kathleen König,… , 10 May 2010. - 15 S.
In: Laboratory investigation, ISSN 1530-0307. 90(2010), 7, Seite 1102-1116
DOI: 10.1038/labinvest.2010.70
Heil, Jörg: Aesthetic and functional results after breast conserving surgery as correlates of quality of life measured by a German version of the Breast Cancer Treatment Outcome Scale (BCTOS) / Joerg Heil; Simone Holl; Michael Golatta; Geraldine Rauch; Joachim Rom; Frederik Marmé; Gerhard Geba… , 2010. - 5 S.
In: The breast, ISSN 0960-9776. 19(2010), 6, Seite 470-474
Rom, Joachim: Oblimersen combined with docetaxel, adriamycin and cyclophosphamide as neo-adjuvant systemic treatment in primary breast cancer: final results of a multicentric phase I study / J. Rom ... B. Schlehe ; F. Marmé ; F. Schütz ... H.-P. Sinn ... C. Sohn ; A. Schneeweiss. - 8 S.
In: Annals of oncology, ISSN 0923-7534. 19(2008), 10, S. 1698-1705
Marmé, Frederik: Funktionelle Untersuchung der Proteintransduktionseffizienz mit Hilfe "zellpermeabler", Tetrazyklin-regulierter Transaktivatoren und Silencer / vorgelegt von Frederik Marmé, 2006. - 161 Bl. : Ill., graph. Darst.

IDs

GND:

132561972

Links

Marmé, Frederik in ...

Export Publikationsliste

heiBIB

Bei fehlerhaften oder unvollständigen Angaben wenden Sie sich bitte an biblio@ub.uni-heidelberg.de.

Informationen zu heiBIB (inkl. Einbettung der Publikationslisten in eigene WWW-Seiten).

Impressum / Datenschutz Design